DrugName,GeneTarget,Num,PathwayID,PathwayName
dexamethasone,NR0B1,1,hsa04927,cortisol synthesis and secretion
dexamethasone,ANXA1,0,,
dexamethasone,NOS2,17,hsa00220;hsa00330;hsa01100;hsa04020;hsa04066;hsa04146;hsa04371;hsa04926;hsa05132;hsa05133;hsa05140;hsa05142;hsa05145;hsa05146;hsa05152;hsa05200;hsa05222,arginine biosynthesis;arginine and proline metabolism;metabolic pathways;calcium signaling pathway;hif-1 signaling pathway;peroxisome;apelin signaling pathway;relaxin signaling pathway;salmonella infection;pertussis;leishmaniasis;chagas disease ;toxoplasmosis;amoebiasis;tuberculosis;pathways in cancer;small cell lung cancer
dexamethasone,NR1I2,0,,
dexamethasone,NR3C1,1,hsa04080,neuroactive ligand-receptor interaction
atorvastatin,HMGCR,4,hsa00900;hsa01100;hsa04152;hsa04976,terpenoid backbone biosynthesis;metabolic pathways;ampk signaling pathway;bile secretion
atorvastatin,DPP4,1,hsa04974,protein digestion and absorption
atorvastatin,AHR,2,hsa04659;hsa04934,th17 cell differentiation;cushing syndrome
atorvastatin,HDAC2,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
atorvastatin,NR1I3,0,,
beta-estradiol,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
beta-estradiol,ESR2,6,hsa01522;hsa04915;hsa04917;hsa04929;hsa05200;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;gnrh secretion;pathways in cancer;breast cancer
beta-estradiol,NR1I2,0,,
beta-estradiol,CHRNA4,3,hsa04080;hsa04725;hsa05033,neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction
beta-estradiol,GPER1,3,hsa01522;hsa04915;hsa04929,endocrine resistance;estrogen signaling pathway;gnrh secretion
beta-estradiol,MT-ATP6,0,,
beta-estradiol,BECN1,8,hsa04136;hsa04137;hsa04140;hsa04215;hsa04371;hsa05017;hsa05131;hsa05167,autophagy - other;mitophagy - animal;autophagy - animal;apoptosis - multiple species;apelin signaling pathway;spinocerebellar ataxia;shigellosis;kaposi sarcoma-associated herpesvirus infection
vorinostat,HDAC1,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
vorinostat,HDAC2,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
vorinostat,HDAC3,3,hsa04919;hsa05034;hsa05203,thyroid hormone signaling pathway;alcoholism;viral carcinogenesis
vorinostat,HDAC6,2,hsa05034;hsa05203,alcoholism;viral carcinogenesis
vorinostat,HDAC8,2,hsa05034;hsa05203,alcoholism;viral carcinogenesis
olanzapine,HTR2A,5,hsa04020;hsa04080;hsa04540;hsa04726;hsa04750,calcium signaling pathway;neuroactive ligand-receptor interaction;gap junction;serotonergic synapse;inflammatory mediator regulation of trp channels
olanzapine,DRD2,8,hsa04015;hsa04024;hsa04080;hsa04540;hsa04728;hsa05012;hsa05030;hsa05034,rap1 signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;gap junction;dopaminergic synapse;parkinson disease;cocaine addiction;alcoholism
olanzapine,DRD1,10,hsa04020;hsa04024;hsa04080;hsa04540;hsa04728;hsa05012;hsa05030;hsa05031;hsa05032;hsa05034,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;gap junction;dopaminergic synapse;parkinson disease;cocaine addiction;amphetamine addiction;morphine addiction;alcoholism
olanzapine,DRD5,4,hsa04020;hsa04024;hsa04080;hsa04728,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;dopaminergic synapse
olanzapine,DRD3,2,hsa04080;hsa04728,neuroactive ligand-receptor interaction;dopaminergic synapse
olanzapine,DRD4,2,hsa04080;hsa04728,neuroactive ligand-receptor interaction;dopaminergic synapse
olanzapine,HTR2C,5,hsa04020;hsa04080;hsa04540;hsa04726;hsa04750,calcium signaling pathway;neuroactive ligand-receptor interaction;gap junction;serotonergic synapse;inflammatory mediator regulation of trp channels
olanzapine,HTR3A,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
olanzapine,HTR6,4,hsa04020;hsa04024;hsa04080;hsa04726,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;serotonergic synapse
olanzapine,HRH1,3,hsa04020;hsa04080;hsa04750,calcium signaling pathway;neuroactive ligand-receptor interaction;inflammatory mediator regulation of trp channels
olanzapine,ADRA1A,7,hsa04020;hsa04022;hsa04080;hsa04152;hsa04261;hsa04270;hsa04970,calcium signaling pathway;cgmp-pkg signaling pathway;neuroactive ligand-receptor interaction;ampk signaling pathway;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;salivary secretion
olanzapine,ADRA1B,6,hsa04020;hsa04022;hsa04080;hsa04261;hsa04270;hsa04970,calcium signaling pathway;cgmp-pkg signaling pathway;neuroactive ligand-receptor interaction;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;salivary secretion
olanzapine,CHRM1,6,hsa04020;hsa04024;hsa04080;hsa04151;hsa04725;hsa04810,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;pi3k-akt signaling pathway;cholinergic synapse;regulation of actin cytoskeleton
olanzapine,CHRM2,6,hsa04020;hsa04024;hsa04080;hsa04151;hsa04725;hsa04810,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;pi3k-akt signaling pathway;cholinergic synapse;regulation of actin cytoskeleton
olanzapine,CHRM3,9,hsa04020;hsa04080;hsa04725;hsa04742;hsa04810;hsa04911;hsa04970;hsa04971;hsa04972,calcium signaling pathway;neuroactive ligand-receptor interaction;cholinergic synapse;taste transduction;regulation of actin cytoskeleton;insulin secretion;salivary secretion;gastric acid secretion;pancreatic secretion
olanzapine,CHRM4,3,hsa04080;hsa04725;hsa04810,neuroactive ligand-receptor interaction;cholinergic synapse;regulation of actin cytoskeleton
cyclosporin a,CAMLG,0,,
cyclosporin a,PPP3R2,29,hsa04010;hsa04020;hsa04022;hsa04114;hsa04218;hsa04310;hsa04360;hsa04370;hsa04380;hsa04625;hsa04650;hsa04658;hsa04659;hsa04660;hsa04662;hsa04720;hsa04724;hsa04921;hsa04922;hsa04924;hsa05010;hsa05014;hsa05031;hsa05152;hsa05163;hsa05166;hsa05167;hsa05170;hsa05235,mapk signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;oocyte meiosis;cellular senescence;wnt signaling pathway;axon guidance;vegf signaling pathway;osteoclast differentiation;c-type lectin receptor signaling pathway;natural killer cell mediated cytotoxicity;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;b cell receptor signaling pathway;long-term potentiation;glutamatergic synapse;oxytocin signaling pathway;glucagon signaling pathway;renin secretion;alzheimer disease;amyotrophic lateral sclerosis ;amphetamine addiction;tuberculosis;human cytomegalovirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pd-l1 expression and pd-1 checkpoint pathway in cancer
cyclosporin a,PPIA,1,hsa04217,necroptosis
cyclosporin a,PPIF,5,hsa04020;hsa04022;hsa05012;hsa05016;hsa05145,calcium signaling pathway;cgmp-pkg signaling pathway;parkinson disease;huntington disease;toxoplasmosis
rosiglitazone,PPARG,9,hsa03320;hsa04152;hsa04211;hsa04380;hsa04714;hsa05016;hsa05200;hsa05202;hsa05216,ppar signaling pathway;ampk signaling pathway;longevity regulating pathway;osteoclast differentiation;thermogenesis;huntington disease;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer
rosiglitazone,ACSL4,9,hsa00061;hsa00071;hsa01100;hsa01212;hsa03320;hsa04146;hsa04216;hsa04714;hsa04920,fatty acid biosynthesis;fatty acid degradation;metabolic pathways;fatty acid metabolism;ppar signaling pathway;peroxisome;ferroptosis;thermogenesis;adipocytokine signaling pathway
rosiglitazone,PPARA,7,hsa03320;hsa04024;hsa04920;hsa04922;hsa04931;hsa04932;hsa05160,ppar signaling pathway;camp signaling pathway;adipocytokine signaling pathway;glucagon signaling pathway;insulin resistance;non-alcoholic fatty liver disease ;hepatitis c
rosiglitazone,PPARD,4,hsa03320;hsa04310;hsa05200;hsa05221,ppar signaling pathway;wnt signaling pathway;pathways in cancer;acute myeloid leukemia
rosiglitazone,RXRA,15,hsa03320;hsa04151;hsa04659;hsa04919;hsa04920;hsa04928;hsa04932;hsa04976;hsa05160;hsa05200;hsa05202;hsa05216;hsa05222;hsa05223;hsa05226,"ppar signaling pathway;pi3k-akt signaling pathway;th17 cell differentiation;thyroid hormone signaling pathway;adipocytokine signaling pathway;parathyroid hormone synthesis, secretion and action;non-alcoholic fatty liver disease ;bile secretion;hepatitis c;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer;small cell lung cancer;non-small cell lung cancer;gastric cancer"
rosiglitazone,RXRB,11,hsa03320;hsa04659;hsa04919;hsa04920;hsa04928;hsa05200;hsa05202;hsa05216;hsa05222;hsa05223;hsa05226,"ppar signaling pathway;th17 cell differentiation;thyroid hormone signaling pathway;adipocytokine signaling pathway;parathyroid hormone synthesis, secretion and action;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer;small cell lung cancer;non-small cell lung cancer;gastric cancer"
rosiglitazone,RXRG,11,hsa03320;hsa04659;hsa04919;hsa04920;hsa04928;hsa05200;hsa05202;hsa05216;hsa05222;hsa05223;hsa05226,"ppar signaling pathway;th17 cell differentiation;thyroid hormone signaling pathway;adipocytokine signaling pathway;parathyroid hormone synthesis, secretion and action;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer;small cell lung cancer;non-small cell lung cancer;gastric cancer"
bosutinib,BCR,2,hsa05200;hsa05220,pathways in cancer;chronic myeloid leukemia
bosutinib,ABL1,11,hsa04012;hsa04014;hsa04110;hsa04360;hsa04722;hsa05130;hsa05131;hsa05200;hsa05206;hsa05220;hsa05416,erbb signaling pathway;ras signaling pathway;cell cycle;axon guidance;neurotrophin signaling pathway;pathogenic escherichia coli infection;shigellosis;pathways in cancer;micrornas in cancer;chronic myeloid leukemia;viral myocarditis
bosutinib,LYN,12,hsa04062;hsa04064;hsa04611;hsa04662;hsa04664;hsa04666;hsa04730;hsa05120;hsa05130;hsa05167;hsa05169;hsa05203,chemokine signaling pathway;nf-kappa b signaling pathway;platelet activation;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;long-term depression;epithelial cell signaling in helicobacter pylori infection;pathogenic escherichia coli infection;kaposi sarcoma-associated herpesvirus infection;epstein-barr virus infection;viral carcinogenesis
bosutinib,HCK,4,hsa04062;hsa04666;hsa05130;hsa05167,chemokine signaling pathway;fc gamma r-mediated phagocytosis;pathogenic escherichia coli infection;kaposi sarcoma-associated herpesvirus infection
bosutinib,SRC,37,hsa01521;hsa01522;hsa04012;hsa04015;hsa04062;hsa04137;hsa04144;hsa04360;hsa04370;hsa04510;hsa04520;hsa04530;hsa04540;hsa04611;hsa04625;hsa04727;hsa04750;hsa04810;hsa04912;hsa04915;hsa04917;hsa04919;hsa04921;hsa04926;hsa05100;hsa05120;hsa05131;hsa05135;hsa05152;hsa05161;hsa05163;hsa05167;hsa05168;hsa05203;hsa05205;hsa05219;hsa05418,egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;rap1 signaling pathway;chemokine signaling pathway;mitophagy - animal;endocytosis;axon guidance;vegf signaling pathway;focal adhesion;adherens junction;tight junction;gap junction;platelet activation;c-type lectin receptor signaling pathway;gabaergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;gnrh signaling pathway;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;bacterial invasion of epithelial cells;epithelial cell signaling in helicobacter pylori infection;shigellosis;yersinia infection;tuberculosis;hepatitis b;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;viral carcinogenesis;proteoglycans in cancer;bladder cancer;fluid shear stress and atherosclerosis
bosutinib,CDK2,19,hsa04068;hsa04110;hsa04114;hsa04115;hsa04151;hsa04218;hsa04914;hsa04934;hsa05160;hsa05161;hsa05162;hsa05165;hsa05166;hsa05169;hsa05200;hsa05203;hsa05215;hsa05222;hsa05226,foxo signaling pathway;cell cycle;oocyte meiosis;p53 signaling pathway;pi3k-akt signaling pathway;cellular senescence;progesterone-mediated oocyte maturation;cushing syndrome;hepatitis c;hepatitis b;measles;human papillomavirus infection;human t-cell leukemia virus 1 infection;epstein-barr virus infection;pathways in cancer;viral carcinogenesis;prostate cancer;small cell lung cancer;gastric cancer
bosutinib,MAP2K1,84,hsa01521;hsa01522;hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04114;hsa04140;hsa04150;hsa04151;hsa04210;hsa04218;hsa04270;hsa04370;hsa04371;hsa04380;hsa04510;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04720;hsa04722;hsa04725;hsa04726;hsa04730;hsa04810;hsa04910;hsa04912;hsa04914;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04926;hsa04928;hsa04929;hsa04934;hsa04935;hsa05020;hsa05034;hsa05135;hsa05160;hsa05161;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;oocyte meiosis;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;apoptosis;cellular senescence;vascular smooth muscle contraction;vegf signaling pathway;apelin signaling pathway;osteoclast differentiation;focal adhesion;gap junction;signaling pathways regulating pluripotency of stem cells;toll-like receptor signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;long-term potentiation;neurotrophin signaling pathway;cholinergic synapse;serotonergic synapse;long-term depression;regulation of actin cytoskeleton;insulin signaling pathway;gnrh signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;parathyroid hormone synthesis, secretion and action;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;prion diseases;alcoholism;yersinia infection;hepatitis c;hepatitis b;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;thyroid cancer;melanoma;bladder cancer;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
bosutinib,MAP2K2,72,hsa01521;hsa01522;hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04066;hsa04068;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04210;hsa04218;hsa04270;hsa04370;hsa04371;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04720;hsa04722;hsa04730;hsa04810;hsa04910;hsa04912;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04926;hsa04929;hsa04934;hsa04935;hsa05020;hsa05135;hsa05160;hsa05161;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05211;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;hif-1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;apoptosis;cellular senescence;vascular smooth muscle contraction;vegf signaling pathway;apelin signaling pathway;gap junction;signaling pathways regulating pluripotency of stem cells;toll-like receptor signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;long-term potentiation;neurotrophin signaling pathway;long-term depression;regulation of actin cytoskeleton;insulin signaling pathway;gnrh signaling pathway;estrogen signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;prion diseases;yersinia infection;hepatitis c;hepatitis b;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;endometrial cancer;glioma;prostate cancer;thyroid cancer;melanoma;bladder cancer;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
bosutinib,MAP3K2,3,hsa04010;hsa04540;hsa04912,mapk signaling pathway;gap junction;gnrh signaling pathway
bosutinib,CAMK2G,29,hsa04012;hsa04020;hsa04024;hsa04066;hsa04114;hsa04217;hsa04261;hsa04310;hsa04360;hsa04713;hsa04720;hsa04722;hsa04725;hsa04728;hsa04740;hsa04750;hsa04911;hsa04912;hsa04916;hsa04921;hsa04922;hsa04925;hsa04934;hsa04971;hsa05031;hsa05152;hsa05200;hsa05205;hsa05214,erbb signaling pathway;calcium signaling pathway;camp signaling pathway;hif-1 signaling pathway;oocyte meiosis;necroptosis;adrenergic signaling in cardiomyocytes;wnt signaling pathway;axon guidance;circadian entrainment;long-term potentiation;neurotrophin signaling pathway;cholinergic synapse;dopaminergic synapse;olfactory transduction;inflammatory mediator regulation of trp channels;insulin secretion;gnrh signaling pathway;melanogenesis;oxytocin signaling pathway;glucagon signaling pathway;aldosterone synthesis and secretion;cushing syndrome;gastric acid secretion;amphetamine addiction;tuberculosis;pathways in cancer;proteoglycans in cancer;glioma
zinc acetate,F2,7,hsa04072;hsa04080;hsa04610;hsa04611;hsa04810;hsa05130;hsa05200,phospholipase d signaling pathway;neuroactive ligand-receptor interaction;complement and coagulation cascades;platelet activation;regulation of actin cytoskeleton;pathogenic escherichia coli infection;pathways in cancer
zinc acetate,MMP9,14,hsa01522;hsa04657;hsa04668;hsa04670;hsa04915;hsa04926;hsa05161;hsa05200;hsa05202;hsa05205;hsa05206;hsa05215;hsa05219;hsa05418,endocrine resistance;il-17 signaling pathway;tnf signaling pathway;leukocyte transendothelial migration;estrogen signaling pathway;relaxin signaling pathway;hepatitis b;pathways in cancer;transcriptional misregulation in cancer;proteoglycans in cancer;micrornas in cancer;prostate cancer;bladder cancer;fluid shear stress and atherosclerosis
zinc acetate,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
zinc acetate,IL3,10,hsa04060;hsa04151;hsa04210;hsa04630;hsa04640;hsa04664;hsa05200;hsa05202;hsa05221;hsa05310,cytokine-cytokine receptor interaction;pi3k-akt signaling pathway;apoptosis;jak-stat signaling pathway;hematopoietic cell lineage;fc epsilon ri signaling pathway;pathways in cancer;transcriptional misregulation in cancer;acute myeloid leukemia;asthma
zinc acetate,HBA1,2,hsa05143;hsa05144,african trypanosomiasis;malaria
zinc acetate,ASPA,3,hsa00250;hsa00340;hsa01100,"alanine, aspartate and glutamate metabolism;histidine metabolism;metabolic pathways"
zinc acetate,SERPINA6,0,,
zinc acetate,TTR,1,hsa04918,thyroid hormone synthesis
zinc acetate,GLRA1,1,hsa04080,neuroactive ligand-receptor interaction
zinc acetate,TF,3,hsa04066;hsa04216;hsa04978,hif-1 signaling pathway;ferroptosis;mineral absorption
zinc acetate,FGA,2,hsa04610;hsa04611,complement and coagulation cascades;platelet activation
zinc acetate,HBB,2,hsa05143;hsa05144,african trypanosomiasis;malaria
zinc acetate,SHBG,0,,
zinc acetate,GAPDHS,2,hsa00010;hsa01100,glycolysis / gluconeogenesis;metabolic pathways
zinc acetate,SERPIND1,1,hsa04610,complement and coagulation cascades
zinc acetate,C5,7,hsa04080;hsa04610;hsa05020;hsa05133;hsa05150;hsa05168;hsa05322,neuroactive ligand-receptor interaction;complement and coagulation cascades;prion diseases;pertussis;staphylococcus aureus infection;herpes simplex virus 1 infection;systemic lupus erythematosus
zinc acetate,A2M,1,hsa04610,complement and coagulation cascades
zinc acetate,APOA2,2,hsa03320;hsa04979,ppar signaling pathway;cholesterol metabolism
zinc acetate,PON1,0,,
zinc acetate,SERPINA1,1,hsa04610,complement and coagulation cascades
zinc acetate,MDM2,25,hsa01522;hsa01524;hsa04068;hsa04110;hsa04115;hsa04120;hsa04144;hsa04151;hsa04218;hsa04625;hsa04919;hsa05131;hsa05163;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05205;hsa05206;hsa05214;hsa05215;hsa05218;hsa05219;hsa05220,endocrine resistance;platinum drug resistance;foxo signaling pathway;cell cycle;p53 signaling pathway;ubiquitin mediated proteolysis;endocytosis;pi3k-akt signaling pathway;cellular senescence;c-type lectin receptor signaling pathway;thyroid hormone signaling pathway;shigellosis;human cytomegalovirus infection;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;glioma;prostate cancer;melanoma;bladder cancer;chronic myeloid leukemia
zinc acetate,KNG1,9,hsa04022;hsa04071;hsa04080;hsa04610;hsa04750;hsa04810;hsa05142;hsa05143;hsa05200,cgmp-pkg signaling pathway;sphingolipid signaling pathway;neuroactive ligand-receptor interaction;complement and coagulation cascades;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;chagas disease ;african trypanosomiasis;pathways in cancer
zinc acetate,AGT,14,hsa04072;hsa04080;hsa04261;hsa04270;hsa04614;hsa04924;hsa04925;hsa04927;hsa04931;hsa04933;hsa04934;hsa05200;hsa05410;hsa05414,phospholipase d signaling pathway;neuroactive ligand-receptor interaction;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;renin-angiotensin system;renin secretion;aldosterone synthesis and secretion;cortisol synthesis and secretion;insulin resistance;age-rage signaling pathway in diabetic complications;cushing syndrome;pathways in cancer;hypertrophic cardiomyopathy ;dilated cardiomyopathy 
zinc acetate,VTN,6,hsa04151;hsa04510;hsa04512;hsa04610;hsa05165;hsa05205,pi3k-akt signaling pathway;focal adhesion;ecm-receptor interaction;complement and coagulation cascades;human papillomavirus infection;proteoglycans in cancer
zinc acetate,APOE,2,hsa04979;hsa05010,cholesterol metabolism;alzheimer disease
zinc acetate,CP,2,hsa00860;hsa04216,porphyrin and chlorophyll metabolism;ferroptosis
zinc acetate,MGMT,0,,
zinc acetate,FN1,12,hsa04151;hsa04510;hsa04512;hsa04810;hsa04933;hsa05100;hsa05135;hsa05146;hsa05165;hsa05200;hsa05205;hsa05222,pi3k-akt signaling pathway;focal adhesion;ecm-receptor interaction;regulation of actin cytoskeleton;age-rage signaling pathway in diabetic complications;bacterial invasion of epithelial cells;yersinia infection;amoebiasis;human papillomavirus infection;pathways in cancer;proteoglycans in cancer;small cell lung cancer
zinc acetate,APCS,0,,
zinc acetate,C1S,4,hsa04610;hsa05133;hsa05150;hsa05322,complement and coagulation cascades;pertussis;staphylococcus aureus infection;systemic lupus erythematosus
zinc acetate,HDAC8,2,hsa05034;hsa05203,alcoholism;viral carcinogenesis
zinc acetate,ALDOA,7,hsa00010;hsa00030;hsa00051;hsa01100;hsa01200;hsa01230;hsa04066,glycolysis / gluconeogenesis;pentose phosphate pathway;fructose and mannose metabolism;metabolic pathways;carbon metabolism;biosynthesis of amino acids;hif-1 signaling pathway
zinc acetate,CFB,2,hsa04610;hsa05150,complement and coagulation cascades;staphylococcus aureus infection
zinc acetate,PARP1,4,hsa03410;hsa04064;hsa04210;hsa04217,base excision repair;nf-kappa b signaling pathway;apoptosis;necroptosis
zinc acetate,C1R,5,hsa04145;hsa04610;hsa05133;hsa05150;hsa05322,phagosome;complement and coagulation cascades;pertussis;staphylococcus aureus infection;systemic lupus erythematosus
zinc acetate,C1QB,6,hsa04610;hsa05020;hsa05133;hsa05142;hsa05150;hsa05322,complement and coagulation cascades;prion diseases;pertussis;chagas disease ;staphylococcus aureus infection;systemic lupus erythematosus
zinc acetate,C1QC,6,hsa04610;hsa05020;hsa05133;hsa05142;hsa05150;hsa05322,complement and coagulation cascades;prion diseases;pertussis;chagas disease ;staphylococcus aureus infection;systemic lupus erythematosus
zinc acetate,HDAC1,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
zinc acetate,SOD1,5,hsa04146;hsa04213;hsa05014;hsa05016;hsa05020,peroxisome;longevity regulating pathway - multiple species;amyotrophic lateral sclerosis ;huntington disease;prion diseases
zinc acetate,KLKB1,1,hsa04610,complement and coagulation cascades
zinc acetate,P4HB,1,hsa04141,protein processing in endoplasmic reticulum
zinc acetate,NME1,4,hsa00230;hsa00240;hsa00983;hsa01100,purine metabolism;pyrimidine metabolism;drug metabolism - other enzymes;metabolic pathways
zinc acetate,C8G,4,hsa04610;hsa05020;hsa05146;hsa05322,complement and coagulation cascades;prion diseases;amoebiasis;systemic lupus erythematosus
zinc acetate,TP53,49,hsa01522;hsa01524;hsa04010;hsa04071;hsa04110;hsa04115;hsa04137;hsa04151;hsa04210;hsa04211;hsa04216;hsa04218;hsa04310;hsa04722;hsa04919;hsa05014;hsa05016;hsa05131;hsa05160;hsa05161;hsa05162;hsa05163;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05200;hsa05202;hsa05203;hsa05205;hsa05206;hsa05210;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05217;hsa05218;hsa05219;hsa05220;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05418,endocrine resistance;platinum drug resistance;mapk signaling pathway;sphingolipid signaling pathway;cell cycle;p53 signaling pathway;mitophagy - animal;pi3k-akt signaling pathway;apoptosis;longevity regulating pathway;ferroptosis;cellular senescence;wnt signaling pathway;neurotrophin signaling pathway;thyroid hormone signaling pathway;amyotrophic lateral sclerosis ;huntington disease;shigellosis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;pancreatic cancer;endometrial cancer;glioma;prostate cancer;thyroid cancer;basal cell carcinoma;melanoma;bladder cancer;chronic myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;fluid shear stress and atherosclerosis
zinc acetate,APP,2,hsa04726;hsa05010,serotonergic synapse;alzheimer disease
zinc acetate,APOA1,5,hsa03320;hsa04975;hsa04977;hsa04979;hsa05143,ppar signaling pathway;fat digestion and absorption;vitamin digestion and absorption;cholesterol metabolism;african trypanosomiasis
zinc acetate,C3,14,hsa04080;hsa04145;hsa04610;hsa05131;hsa05133;hsa05134;hsa05140;hsa05142;hsa05150;hsa05152;hsa05167;hsa05168;hsa05203;hsa05322,neuroactive ligand-receptor interaction;phagosome;complement and coagulation cascades;shigellosis;pertussis;legionellosis;leishmaniasis;chagas disease ;staphylococcus aureus infection;tuberculosis;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;viral carcinogenesis;systemic lupus erythematosus
zinc acetate,INS,28,hsa04010;hsa04014;hsa04015;hsa04022;hsa04066;hsa04068;hsa04072;hsa04114;hsa04140;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04810;hsa04910;hsa04911;hsa04913;hsa04914;hsa04917;hsa04923;hsa04930;hsa04931;hsa04932;hsa04940;hsa04950;hsa04960;hsa05215,mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phospholipase d signaling pathway;oocyte meiosis;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;longevity regulating pathway;longevity regulating pathway - multiple species;regulation of actin cytoskeleton;insulin signaling pathway;insulin secretion;ovarian steroidogenesis;progesterone-mediated oocyte maturation;prolactin signaling pathway;regulation of lipolysis in adipocytes;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;type i diabetes mellitus;maturity onset diabetes of the young;aldosterone-regulated sodium reabsorption;prostate cancer
zinc acetate,CPN1,0,,
zinc acetate,CPN2,0,,
zinc acetate,HDAC4,4,hsa04371;hsa05034;hsa05203;hsa05206,apelin signaling pathway;alcoholism;viral carcinogenesis;micrornas in cancer
zinc acetate,S100A2,0,,
zinc acetate,ORM2,0,,
zinc acetate,S100A7,1,hsa04657,il-17 signaling pathway
zinc acetate,TPI1,6,hsa00010;hsa00051;hsa00562;hsa01100;hsa01200;hsa01230,glycolysis / gluconeogenesis;fructose and mannose metabolism;inositol phosphate metabolism;metabolic pathways;carbon metabolism;biosynthesis of amino acids
zinc acetate,GSN,3,hsa04666;hsa04810;hsa05203,fc gamma r-mediated phagocytosis;regulation of actin cytoskeleton;viral carcinogenesis
zinc acetate,EEF1A1,3,hsa03013;hsa05134;hsa05140,rna transport;legionellosis;leishmaniasis
zinc acetate,TUFM,0,,
zinc acetate,PSPH,4,hsa00260;hsa01100;hsa01200;hsa01230,"glycine, serine and threonine metabolism;metabolic pathways;carbon metabolism;biosynthesis of amino acids"
zinc acetate,PGLYRP2,0,,
zinc acetate,F12,1,hsa04610,complement and coagulation cascades
zinc acetate,C4B,4,hsa04610;hsa05133;hsa05150;hsa05322,complement and coagulation cascades;pertussis;staphylococcus aureus infection;systemic lupus erythematosus
zinc acetate,MT1A,1,hsa04978,mineral absorption
zinc acetate,MT2A,1,hsa04978,mineral absorption
zinc acetate,IGHA1,0,,
zinc acetate,IGHM,0,,
zinc acetate,SEPP1,0,,
zinc acetate,DAND5,0,,
zinc acetate,MT3,0,,
zinc acetate,ENO1,6,hsa00010;hsa01100;hsa01200;hsa01230;hsa03018;hsa04066,glycolysis / gluconeogenesis;metabolic pathways;carbon metabolism;biosynthesis of amino acids;rna degradation;hif-1 signaling pathway
zinc acetate,PDCD6,0,,
zinc acetate,CCS,1,hsa05014,amyotrophic lateral sclerosis 
zinc acetate,BDKRB1,6,hsa04020;hsa04080;hsa04610;hsa04750;hsa04810;hsa05200,calcium signaling pathway;neuroactive ligand-receptor interaction;complement and coagulation cascades;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;pathways in cancer
zinc acetate,SEMG1,0,,
zinc acetate,SIVA1,1,hsa04115,p53 signaling pathway
zinc acetate,UTRN,0,,
zinc acetate,PRDX1,2,hsa04146;hsa05146,peroxisome;amoebiasis
zinc acetate,APOBR,0,,
zinc acetate,MPG,1,hsa03410,base excision repair
zinc acetate,S100A8,1,hsa04657,il-17 signaling pathway
zinc acetate,PDIA3,6,hsa04141;hsa04612;hsa05163;hsa05168;hsa05169;hsa05170,protein processing in endoplasmic reticulum;antigen processing and presentation;human cytomegalovirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection
zinc acetate,S100A9,1,hsa04657,il-17 signaling pathway
zinc acetate,TP73,4,hsa04115;hsa04390;hsa04722;hsa05162,p53 signaling pathway;hippo signaling pathway;neurotrophin signaling pathway;measles
zinc acetate,A1BG,0,,
zinc acetate,AHSG,0,,
zinc acetate,APOA4,3,hsa04975;hsa04977;hsa04979,fat digestion and absorption;vitamin digestion and absorption;cholesterol metabolism
zinc acetate,C4BPA,2,hsa04610;hsa05133,complement and coagulation cascades;pertussis
zinc acetate,C8B,4,hsa04610;hsa05020;hsa05146;hsa05322,complement and coagulation cascades;prion diseases;amoebiasis;systemic lupus erythematosus
zinc acetate,CFH,2,hsa04610;hsa05150,complement and coagulation cascades;staphylococcus aureus infection
zinc acetate,CFI,2,hsa04610;hsa05150,complement and coagulation cascades;staphylococcus aureus infection
zinc acetate,CLU,1,hsa04610,complement and coagulation cascades
zinc acetate,HPR,1,hsa05143,african trypanosomiasis
zinc acetate,IGFALS,1,hsa04935,"growth hormone synthesis, secretion and action"
zinc acetate,ITIH2,0,,
zinc acetate,KRT1,0,,
zinc acetate,KRT10,2,hsa04915;hsa05150,estrogen signaling pathway;staphylococcus aureus infection
zinc acetate,KRT2,0,,
zinc acetate,KRT9,2,hsa04915;hsa05150,estrogen signaling pathway;staphylococcus aureus infection
zinc acetate,SERPINA4,0,,
zinc acetate,APOL1,1,hsa05143,african trypanosomiasis
zinc acetate,C4BPB,2,hsa04610;hsa05133,complement and coagulation cascades;pertussis
zinc acetate,BRCC3,2,hsa03440;hsa04621,homologous recombination;nod-like receptor signaling pathway
zinc acetate,C8A,4,hsa04610;hsa05020;hsa05146;hsa05322,complement and coagulation cascades;prion diseases;amoebiasis;systemic lupus erythematosus
zinc acetate,DCD,0,,
zinc acetate,DSP,1,hsa05412,arrhythmogenic right ventricular cardiomyopathy 
zinc acetate,F13B,1,hsa04610,complement and coagulation cascades
zinc acetate,FCN3,0,,
zinc acetate,HRNR,0,,
zinc acetate,IGKV1-17,0,,
zinc acetate,IGLV3-21,0,,
zinc acetate,ITIH1,0,,
zinc acetate,ITIH3,0,,
zinc acetate,ITIH4,0,,
zinc acetate,JCHAIN,0,,
zinc acetate,JUP,5,hsa05200;hsa05202;hsa05221;hsa05226;hsa05412,pathways in cancer;transcriptional misregulation in cancer;acute myeloid leukemia;gastric cancer;arrhythmogenic right ventricular cardiomyopathy 
zinc acetate,KRT14,2,hsa04915;hsa05150,estrogen signaling pathway;staphylococcus aureus infection
zinc acetate,KRT16,2,hsa04915;hsa05150,estrogen signaling pathway;staphylococcus aureus infection
zinc acetate,KRT5,0,,
zinc acetate,KRT6A,0,,
zinc acetate,PZP,0,,
zinc acetate,SERPINA3,0,,
zinc acetate,APLP1,0,,
zinc acetate,APLP2,0,,
dasatinib,ABL1,11,hsa04012;hsa04014;hsa04110;hsa04360;hsa04722;hsa05130;hsa05131;hsa05200;hsa05206;hsa05220;hsa05416,erbb signaling pathway;ras signaling pathway;cell cycle;axon guidance;neurotrophin signaling pathway;pathogenic escherichia coli infection;shigellosis;pathways in cancer;micrornas in cancer;chronic myeloid leukemia;viral myocarditis
dasatinib,PDGFRB,19,hsa01521;hsa04010;hsa04014;hsa04015;hsa04020;hsa04072;hsa04151;hsa04510;hsa04540;hsa04630;hsa04810;hsa05165;hsa05200;hsa05206;hsa05214;hsa05215;hsa05218;hsa05230;hsa05231,egfr tyrosine kinase inhibitor resistance;mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;focal adhesion;gap junction;jak-stat signaling pathway;regulation of actin cytoskeleton;human papillomavirus infection;pathways in cancer;micrornas in cancer;glioma;prostate cancer;melanoma;central carbon metabolism in cancer;choline metabolism in cancer
dasatinib,PPAT,3,hsa00230;hsa00250;hsa01100,"purine metabolism;alanine, aspartate and glutamate metabolism;metabolic pathways"
dasatinib,ABL2,3,hsa04012;hsa04014;hsa05416,erbb signaling pathway;ras signaling pathway;viral myocarditis
dasatinib,KIT,11,hsa04010;hsa04014;hsa04015;hsa04072;hsa04151;hsa04640;hsa04916;hsa05200;hsa05221;hsa05224;hsa05230,mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;hematopoietic cell lineage;melanogenesis;pathways in cancer;acute myeloid leukemia;breast cancer;central carbon metabolism in cancer
dasatinib,SRC,37,hsa01521;hsa01522;hsa04012;hsa04015;hsa04062;hsa04137;hsa04144;hsa04360;hsa04370;hsa04510;hsa04520;hsa04530;hsa04540;hsa04611;hsa04625;hsa04727;hsa04750;hsa04810;hsa04912;hsa04915;hsa04917;hsa04919;hsa04921;hsa04926;hsa05100;hsa05120;hsa05131;hsa05135;hsa05152;hsa05161;hsa05163;hsa05167;hsa05168;hsa05203;hsa05205;hsa05219;hsa05418,egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;rap1 signaling pathway;chemokine signaling pathway;mitophagy - animal;endocytosis;axon guidance;vegf signaling pathway;focal adhesion;adherens junction;tight junction;gap junction;platelet activation;c-type lectin receptor signaling pathway;gabaergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;gnrh signaling pathway;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;bacterial invasion of epithelial cells;epithelial cell signaling in helicobacter pylori infection;shigellosis;yersinia infection;tuberculosis;hepatitis b;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;viral carcinogenesis;proteoglycans in cancer;bladder cancer;fluid shear stress and atherosclerosis
dasatinib,FYN,14,hsa04071;hsa04072;hsa04360;hsa04380;hsa04510;hsa04520;hsa04611;hsa04650;hsa04660;hsa04664;hsa04725;hsa05020;hsa05130;hsa05416,sphingolipid signaling pathway;phospholipase d signaling pathway;axon guidance;osteoclast differentiation;focal adhesion;adherens junction;platelet activation;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;fc epsilon ri signaling pathway;cholinergic synapse;prion diseases;pathogenic escherichia coli infection;viral myocarditis
dasatinib,YES1,1,hsa04520,adherens junction
dasatinib,EPHA2,5,hsa04010;hsa04014;hsa04015;hsa04151;hsa04360,mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;pi3k-akt signaling pathway;axon guidance
dasatinib,LCK,10,hsa04064;hsa04380;hsa04650;hsa04658;hsa04659;hsa04660;hsa05135;hsa05166;hsa05235;hsa05340,nf-kappa b signaling pathway;osteoclast differentiation;natural killer cell mediated cytotoxicity;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;yersinia infection;human t-cell leukemia virus 1 infection;pd-l1 expression and pd-1 checkpoint pathway in cancer;primary immunodeficiency
dasatinib,STAT5B,17,hsa04012;hsa04062;hsa04217;hsa04630;hsa04658;hsa04659;hsa04917;hsa04933;hsa04935;hsa05161;hsa05162;hsa05166;hsa05200;hsa05203;hsa05220;hsa05221;hsa05223,"erbb signaling pathway;chemokine signaling pathway;necroptosis;jak-stat signaling pathway;th1 and th2 cell differentiation;th17 cell differentiation;prolactin signaling pathway;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;hepatitis b;measles;human t-cell leukemia virus 1 infection;pathways in cancer;viral carcinogenesis;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer"
dasatinib,MAPK14,53,hsa01522;hsa04010;hsa04015;hsa04068;hsa04071;hsa04114;hsa04218;hsa04261;hsa04370;hsa04380;hsa04550;hsa04611;hsa04620;hsa04621;hsa04622;hsa04625;hsa04657;hsa04658;hsa04659;hsa04660;hsa04664;hsa04668;hsa04670;hsa04714;hsa04722;hsa04723;hsa04728;hsa04750;hsa04912;hsa04914;hsa04917;hsa04926;hsa04933;hsa04935;hsa05014;hsa05120;hsa05130;hsa05131;hsa05132;hsa05133;hsa05135;hsa05140;hsa05142;hsa05145;hsa05152;hsa05161;hsa05163;hsa05167;hsa05169;hsa05170;hsa05205;hsa05235;hsa05418,"endocrine resistance;mapk signaling pathway;rap1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;oocyte meiosis;cellular senescence;adrenergic signaling in cardiomyocytes;vegf signaling pathway;osteoclast differentiation;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;nod-like receptor signaling pathway;rig-i-like receptor signaling pathway;c-type lectin receptor signaling pathway;il-17 signaling pathway;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;fc epsilon ri signaling pathway;tnf signaling pathway;leukocyte transendothelial migration;thermogenesis;neurotrophin signaling pathway;retrograde endocannabinoid signaling;dopaminergic synapse;inflammatory mediator regulation of trp channels;gnrh signaling pathway;progesterone-mediated oocyte maturation;prolactin signaling pathway;relaxin signaling pathway;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;amyotrophic lateral sclerosis ;epithelial cell signaling in helicobacter pylori infection;pathogenic escherichia coli infection;shigellosis;salmonella infection;pertussis;yersinia infection;leishmaniasis;chagas disease ;toxoplasmosis;tuberculosis;hepatitis b;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;proteoglycans in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
dasatinib,BTK,7,hsa04064;hsa04380;hsa04611;hsa04662;hsa04664;hsa05169;hsa05340,nf-kappa b signaling pathway;osteoclast differentiation;platelet activation;b cell receptor signaling pathway;fc epsilon ri signaling pathway;epstein-barr virus infection;primary immunodeficiency
dasatinib,CSK,1,hsa05120,epithelial cell signaling in helicobacter pylori infection
dasatinib,EPHB4,1,hsa04360,axon guidance
dasatinib,HSPA8,10,hsa03040;hsa04010;hsa04141;hsa04144;hsa04213;hsa04612;hsa04915;hsa05134;hsa05145;hsa05162,spliceosome;mapk signaling pathway;protein processing in endoplasmic reticulum;endocytosis;longevity regulating pathway - multiple species;antigen processing and presentation;estrogen signaling pathway;legionellosis;toxoplasmosis;measles
dasatinib,LYN,12,hsa04062;hsa04064;hsa04611;hsa04662;hsa04664;hsa04666;hsa04730;hsa05120;hsa05130;hsa05167;hsa05169;hsa05203,chemokine signaling pathway;nf-kappa b signaling pathway;platelet activation;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;long-term depression;epithelial cell signaling in helicobacter pylori infection;pathogenic escherichia coli infection;kaposi sarcoma-associated herpesvirus infection;epstein-barr virus infection;viral carcinogenesis
dasatinib,FRK,0,,
dasatinib,BCR,2,hsa05200;hsa05220,pathways in cancer;chronic myeloid leukemia
dasatinib,FGR,1,hsa04062,chemokine signaling pathway
dasatinib,EPHA5,1,hsa04360,axon guidance
dasatinib,ZAK,0,,
dasatinib,NR4A3,1,hsa05202,transcriptional misregulation in cancer
mercaptopurine,HPRT1,3,hsa00230;hsa00983;hsa01100,purine metabolism;drug metabolism - other enzymes;metabolic pathways
mercaptopurine,PPAT,3,hsa00230;hsa00250;hsa01100,"purine metabolism;alanine, aspartate and glutamate metabolism;metabolic pathways"
raloxifene,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
raloxifene,ESR2,6,hsa01522;hsa04915;hsa04917;hsa04929;hsa05200;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;gnrh secretion;pathways in cancer;breast cancer
raloxifene,SERPINB9,1,hsa05146,amoebiasis
raloxifene,TFF1,1,hsa04915,estrogen signaling pathway
cytarabine,POLB,3,hsa03410;hsa05166;hsa05203,base excision repair;human t-cell leukemia virus 1 infection;viral carcinogenesis
imatinib,BCR,2,hsa05200;hsa05220,pathways in cancer;chronic myeloid leukemia
imatinib,KIT,11,hsa04010;hsa04014;hsa04015;hsa04072;hsa04151;hsa04640;hsa04916;hsa05200;hsa05221;hsa05224;hsa05230,mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;hematopoietic cell lineage;melanogenesis;pathways in cancer;acute myeloid leukemia;breast cancer;central carbon metabolism in cancer
imatinib,RET,3,hsa05200;hsa05216;hsa05230,pathways in cancer;thyroid cancer;central carbon metabolism in cancer
imatinib,NTRK1,10,hsa04010;hsa04014;hsa04151;hsa04210;hsa04722;hsa04750;hsa05200;hsa05202;hsa05216;hsa05230,mapk signaling pathway;ras signaling pathway;pi3k-akt signaling pathway;apoptosis;neurotrophin signaling pathway;inflammatory mediator regulation of trp channels;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer;central carbon metabolism in cancer
imatinib,CSF1R,11,hsa04010;hsa04014;hsa04015;hsa04060;hsa04061;hsa04151;hsa04380;hsa04640;hsa05200;hsa05202;hsa05221,mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;cytokine-cytokine receptor interaction;viral protein interaction with cytokine and cytokine receptor;pi3k-akt signaling pathway;osteoclast differentiation;hematopoietic cell lineage;pathways in cancer;transcriptional misregulation in cancer;acute myeloid leukemia
imatinib,PDGFRA,20,hsa01521;hsa04010;hsa04014;hsa04015;hsa04020;hsa04072;hsa04144;hsa04151;hsa04510;hsa04540;hsa04630;hsa04810;hsa05163;hsa05200;hsa05206;hsa05214;hsa05215;hsa05218;hsa05230;hsa05231,egfr tyrosine kinase inhibitor resistance;mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;phospholipase d signaling pathway;endocytosis;pi3k-akt signaling pathway;focal adhesion;gap junction;jak-stat signaling pathway;regulation of actin cytoskeleton;human cytomegalovirus infection;pathways in cancer;micrornas in cancer;glioma;prostate cancer;melanoma;central carbon metabolism in cancer;choline metabolism in cancer
imatinib,DDR1,0,,
imatinib,ABL1,11,hsa04012;hsa04014;hsa04110;hsa04360;hsa04722;hsa05130;hsa05131;hsa05200;hsa05206;hsa05220;hsa05416,erbb signaling pathway;ras signaling pathway;cell cycle;axon guidance;neurotrophin signaling pathway;pathogenic escherichia coli infection;shigellosis;pathways in cancer;micrornas in cancer;chronic myeloid leukemia;viral myocarditis
imatinib,PDGFRB,19,hsa01521;hsa04010;hsa04014;hsa04015;hsa04020;hsa04072;hsa04151;hsa04510;hsa04540;hsa04630;hsa04810;hsa05165;hsa05200;hsa05206;hsa05214;hsa05215;hsa05218;hsa05230;hsa05231,egfr tyrosine kinase inhibitor resistance;mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;focal adhesion;gap junction;jak-stat signaling pathway;regulation of actin cytoskeleton;human papillomavirus infection;pathways in cancer;micrornas in cancer;glioma;prostate cancer;melanoma;central carbon metabolism in cancer;choline metabolism in cancer
alcohol,CACNB1,7,hsa04010;hsa04260;hsa04261;hsa04921;hsa05410;hsa05412;hsa05414,mapk signaling pathway;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;oxytocin signaling pathway;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy 
alcohol,HTR3A,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
alcohol,GABRA2,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,CHRNA10,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,CACNA1C,31,hsa04010;hsa04020;hsa04022;hsa04024;hsa04260;hsa04261;hsa04270;hsa04713;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04742;hsa04911;hsa04912;hsa04921;hsa04924;hsa04925;hsa04927;hsa04929;hsa04930;hsa04934;hsa04935;hsa05010;hsa05031;hsa05410;hsa05412;hsa05414,"mapk signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;circadian entrainment;long-term potentiation;retrograde endocannabinoid signaling;glutamatergic synapse;cholinergic synapse;serotonergic synapse;gabaergic synapse;dopaminergic synapse;taste transduction;insulin secretion;gnrh signaling pathway;oxytocin signaling pathway;renin secretion;aldosterone synthesis and secretion;cortisol synthesis and secretion;gnrh secretion;type ii diabetes mellitus;cushing syndrome;growth hormone synthesis, secretion and action;alzheimer disease;amphetamine addiction;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy "
alcohol,GLRA1,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,GABRA5,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,GABRA4,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,GABRA3,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,GRIA1,12,hsa04024;hsa04080;hsa04713;hsa04720;hsa04723;hsa04724;hsa04728;hsa04730;hsa05014;hsa05017;hsa05031;hsa05033,camp signaling pathway;neuroactive ligand-receptor interaction;circadian entrainment;long-term potentiation;retrograde endocannabinoid signaling;glutamatergic synapse;dopaminergic synapse;long-term depression;amyotrophic lateral sclerosis ;spinocerebellar ataxia;amphetamine addiction;nicotine addiction
alcohol,GRIN3A,8,hsa04024;hsa04080;hsa04724;hsa05017;hsa05030;hsa05031;hsa05033;hsa05034,camp signaling pathway;neuroactive ligand-receptor interaction;glutamatergic synapse;spinocerebellar ataxia;cocaine addiction;amphetamine addiction;nicotine addiction;alcoholism
alcohol,CACNG1,7,hsa04010;hsa04260;hsa04261;hsa04921;hsa05410;hsa05412;hsa05414,mapk signaling pathway;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;oxytocin signaling pathway;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy 
alcohol,CHRNA2,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,GLRA2,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,GABRA6,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,GABRA1,6,hsa04080;hsa04723;hsa04727;hsa04742;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;taste transduction;morphine addiction;nicotine addiction
alcohol,GRIA2,13,hsa04024;hsa04080;hsa04713;hsa04720;hsa04723;hsa04724;hsa04728;hsa04730;hsa05014;hsa05017;hsa05030;hsa05031;hsa05033,camp signaling pathway;neuroactive ligand-receptor interaction;circadian entrainment;long-term potentiation;retrograde endocannabinoid signaling;glutamatergic synapse;dopaminergic synapse;long-term depression;amyotrophic lateral sclerosis ;spinocerebellar ataxia;cocaine addiction;amphetamine addiction;nicotine addiction
alcohol,GRIA4,8,hsa04024;hsa04080;hsa04713;hsa04723;hsa04724;hsa04728;hsa05031;hsa05033,camp signaling pathway;neuroactive ligand-receptor interaction;circadian entrainment;retrograde endocannabinoid signaling;glutamatergic synapse;dopaminergic synapse;amphetamine addiction;nicotine addiction
alcohol,GRIA3,11,hsa04024;hsa04080;hsa04713;hsa04723;hsa04724;hsa04728;hsa04730;hsa05017;hsa05031;hsa05033;hsa05202,camp signaling pathway;neuroactive ligand-receptor interaction;circadian entrainment;retrograde endocannabinoid signaling;glutamatergic synapse;dopaminergic synapse;long-term depression;spinocerebellar ataxia;amphetamine addiction;nicotine addiction;transcriptional misregulation in cancer
alcohol,CHRNA4,3,hsa04080;hsa04725;hsa05033,neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction
alcohol,CHRNB2,3,hsa04080;hsa04725;hsa05033,neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction
alcohol,KCNJ3,10,hsa04713;hsa04723;hsa04724;hsa04725;hsa04726;hsa04728;hsa04915;hsa04921;hsa04929;hsa05032,circadian entrainment;retrograde endocannabinoid signaling;glutamatergic synapse;cholinergic synapse;serotonergic synapse;dopaminergic synapse;estrogen signaling pathway;oxytocin signaling pathway;gnrh secretion;morphine addiction
alcohol,KCNJ6,10,hsa04713;hsa04723;hsa04725;hsa04726;hsa04727;hsa04728;hsa04915;hsa04921;hsa04929;hsa05032,circadian entrainment;retrograde endocannabinoid signaling;cholinergic synapse;serotonergic synapse;gabaergic synapse;dopaminergic synapse;estrogen signaling pathway;oxytocin signaling pathway;gnrh secretion;morphine addiction
alcohol,VCAM1,8,hsa04064;hsa04514;hsa04668;hsa04670;hsa04933;hsa05143;hsa05144;hsa05418,nf-kappa b signaling pathway;cell adhesion molecules ;tnf signaling pathway;leukocyte transendothelial migration;age-rage signaling pathway in diabetic complications;african trypanosomiasis;malaria;fluid shear stress and atherosclerosis
alcohol,SLC29A1,1,hsa05034,alcoholism
alcohol,KCNJ5,9,hsa04713;hsa04723;hsa04726;hsa04728;hsa04915;hsa04921;hsa04925;hsa04929;hsa05032,circadian entrainment;retrograde endocannabinoid signaling;serotonergic synapse;dopaminergic synapse;estrogen signaling pathway;oxytocin signaling pathway;aldosterone synthesis and secretion;gnrh secretion;morphine addiction
alcohol,CHRNA7,5,hsa04020;hsa04080;hsa04725;hsa05033;hsa05204,calcium signaling pathway;neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction;chemical carcinogenesis
alcohol,CHRNA9,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,GABRB1,6,hsa04080;hsa04723;hsa04726;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;serotonergic synapse;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRB3,6,hsa04080;hsa04723;hsa04726;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;serotonergic synapse;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRB2,6,hsa04080;hsa04723;hsa04726;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;serotonergic synapse;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,CACNA1S,24,hsa04010;hsa04020;hsa04022;hsa04024;hsa04260;hsa04261;hsa04270;hsa04723;hsa04725;hsa04726;hsa04727;hsa04911;hsa04912;hsa04921;hsa04924;hsa04925;hsa04927;hsa04929;hsa04934;hsa04935;hsa05010;hsa05410;hsa05412;hsa05414,"mapk signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;retrograde endocannabinoid signaling;cholinergic synapse;serotonergic synapse;gabaergic synapse;insulin secretion;gnrh signaling pathway;oxytocin signaling pathway;renin secretion;aldosterone synthesis and secretion;cortisol synthesis and secretion;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;alzheimer disease;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy "
alcohol,CACNA1D,32,hsa04010;hsa04020;hsa04022;hsa04024;hsa04218;hsa04260;hsa04261;hsa04270;hsa04530;hsa04713;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04911;hsa04912;hsa04921;hsa04924;hsa04925;hsa04927;hsa04929;hsa04930;hsa04934;hsa04935;hsa04973;hsa05010;hsa05031;hsa05410;hsa05412;hsa05414,"mapk signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;cellular senescence;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;tight junction;circadian entrainment;retrograde endocannabinoid signaling;glutamatergic synapse;cholinergic synapse;serotonergic synapse;gabaergic synapse;dopaminergic synapse;insulin secretion;gnrh signaling pathway;oxytocin signaling pathway;renin secretion;aldosterone synthesis and secretion;cortisol synthesis and secretion;gnrh secretion;type ii diabetes mellitus;cushing syndrome;growth hormone synthesis, secretion and action;carbohydrate digestion and absorption;alzheimer disease;amphetamine addiction;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy "
alcohol,CHRNB4,2,hsa04080;hsa04725,neuroactive ligand-receptor interaction;cholinergic synapse
alcohol,CHRNA3,2,hsa04080;hsa04725,neuroactive ligand-receptor interaction;cholinergic synapse
alcohol,CHRNA5,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,CHRNA6,3,hsa04080;hsa04725;hsa05033,neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction
alcohol,CHRNB3,1,hsa04080,neuroactive ligand-receptor interaction
alcohol,GABRG1,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRG3,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRE,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRP,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRQ,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,GABRD,5,hsa04080;hsa04723;hsa04727;hsa05032;hsa05033,neuroactive ligand-receptor interaction;retrograde endocannabinoid signaling;gabaergic synapse;morphine addiction;nicotine addiction
alcohol,SLC29A2,1,hsa05034,alcoholism
alcohol,CACNG2,7,hsa04010;hsa04260;hsa04261;hsa04921;hsa05410;hsa05412;hsa05414,mapk signaling pathway;cardiac muscle contraction;adrenergic signaling in cardiomyocytes;oxytocin signaling pathway;hypertrophic cardiomyopathy ;arrhythmogenic right ventricular cardiomyopathy ;dilated cardiomyopathy 
alcohol,KCNJ9,8,hsa04713;hsa04723;hsa04726;hsa04728;hsa04915;hsa04921;hsa04929;hsa05032,circadian entrainment;retrograde endocannabinoid signaling;serotonergic synapse;dopaminergic synapse;estrogen signaling pathway;oxytocin signaling pathway;gnrh secretion;morphine addiction
alcohol,L1CAM,2,hsa04360;hsa04514,axon guidance;cell adhesion molecules 
alcohol,HTR3B,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
alcohol,HTR3C,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
alcohol,HTR3D,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
alcohol,HTR3E,2,hsa04726;hsa04742,serotonergic synapse;taste transduction
selumetinib,MAP2K1,84,hsa01521;hsa01522;hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04114;hsa04140;hsa04150;hsa04151;hsa04210;hsa04218;hsa04270;hsa04370;hsa04371;hsa04380;hsa04510;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04720;hsa04722;hsa04725;hsa04726;hsa04730;hsa04810;hsa04910;hsa04912;hsa04914;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04926;hsa04928;hsa04929;hsa04934;hsa04935;hsa05020;hsa05034;hsa05135;hsa05160;hsa05161;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;oocyte meiosis;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;apoptosis;cellular senescence;vascular smooth muscle contraction;vegf signaling pathway;apelin signaling pathway;osteoclast differentiation;focal adhesion;gap junction;signaling pathways regulating pluripotency of stem cells;toll-like receptor signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;long-term potentiation;neurotrophin signaling pathway;cholinergic synapse;serotonergic synapse;long-term depression;regulation of actin cytoskeleton;insulin signaling pathway;gnrh signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;parathyroid hormone synthesis, secretion and action;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;prion diseases;alcoholism;yersinia infection;hepatitis c;hepatitis b;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;thyroid cancer;melanoma;bladder cancer;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
selumetinib,MAP2K2,72,hsa01521;hsa01522;hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04066;hsa04068;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04210;hsa04218;hsa04270;hsa04370;hsa04371;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04720;hsa04722;hsa04730;hsa04810;hsa04910;hsa04912;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04926;hsa04929;hsa04934;hsa04935;hsa05020;hsa05135;hsa05160;hsa05161;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05211;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;hif-1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;apoptosis;cellular senescence;vascular smooth muscle contraction;vegf signaling pathway;apelin signaling pathway;gap junction;signaling pathways regulating pluripotency of stem cells;toll-like receptor signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;long-term potentiation;neurotrophin signaling pathway;long-term depression;regulation of actin cytoskeleton;insulin signaling pathway;gnrh signaling pathway;estrogen signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;prion diseases;yersinia infection;hepatitis c;hepatitis b;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;endometrial cancer;glioma;prostate cancer;thyroid cancer;melanoma;bladder cancer;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
azd-8055,MTOR,44,hsa01521;hsa01522;hsa04012;hsa04066;hsa04072;hsa04136;hsa04140;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04218;hsa04371;hsa04630;hsa04659;hsa04714;hsa04910;hsa04919;hsa04920;hsa04930;hsa04931;hsa04935;hsa05017;hsa05131;hsa05163;hsa05165;hsa05167;hsa05168;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05212;hsa05214;hsa05215;hsa05221;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;hif-1 signaling pathway;phospholipase d signaling pathway;autophagy - other;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;apelin signaling pathway;jak-stat signaling pathway;th17 cell differentiation;thermogenesis;insulin signaling pathway;thyroid hormone signaling pathway;adipocytokine signaling pathway;type ii diabetes mellitus;insulin resistance;growth hormone synthesis, secretion and action;spinocerebellar ataxia;shigellosis;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;pancreatic cancer;glioma;prostate cancer;acute myeloid leukemia;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
avrainvillamide-analog-3,NPM1,0,,
linsitinib,IGF1R,29,hsa01521;hsa01522;hsa04010;hsa04014;hsa04015;hsa04066;hsa04068;hsa04114;hsa04140;hsa04144;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04510;hsa04520;hsa04550;hsa04730;hsa04913;hsa04914;hsa05200;hsa05202;hsa05205;hsa05214;hsa05215;hsa05218;hsa05224;hsa05225,egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;ras signaling pathway;rap1 signaling pathway;hif-1 signaling pathway;foxo signaling pathway;oocyte meiosis;autophagy - animal;endocytosis;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;longevity regulating pathway;longevity regulating pathway - multiple species;focal adhesion;adherens junction;signaling pathways regulating pluripotency of stem cells;long-term depression;ovarian steroidogenesis;progesterone-mediated oocyte maturation;pathways in cancer;transcriptional misregulation in cancer;proteoglycans in cancer;glioma;prostate cancer;melanoma;breast cancer;hepatocellular carcinoma
fluocinolone acetonide,NR3C1,1,hsa04080,neuroactive ligand-receptor interaction
fluocinolone acetonide,ANXA1,0,,
fluocinolone acetonide,ANXA2,0,,
fluocinolone acetonide,ANXA3,0,,
fluocinolone acetonide,ANXA4,0,,
fluocinolone acetonide,ANXA5,0,,
dobutamine,ADRB1,10,hsa04020;hsa04022;hsa04024;hsa04080;hsa04261;hsa04540;hsa04923;hsa04924;hsa04970;hsa05414,calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;adrenergic signaling in cardiomyocytes;gap junction;regulation of lipolysis in adipocytes;renin secretion;salivary secretion;dilated cardiomyopathy 
dobutamine,ADRB2,8,hsa04020;hsa04022;hsa04024;hsa04080;hsa04261;hsa04923;hsa04924;hsa04970,calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;adrenergic signaling in cardiomyocytes;regulation of lipolysis in adipocytes;renin secretion;salivary secretion
dobutamine,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
bromfenac,PTGS2,20,hsa00590;hsa01100;hsa04064;hsa04370;hsa04625;hsa04657;hsa04668;hsa04723;hsa04726;hsa04913;hsa04921;hsa04923;hsa05140;hsa05163;hsa05165;hsa05167;hsa05200;hsa05204;hsa05206;hsa05222,arachidonic acid metabolism;metabolic pathways;nf-kappa b signaling pathway;vegf signaling pathway;c-type lectin receptor signaling pathway;il-17 signaling pathway;tnf signaling pathway;retrograde endocannabinoid signaling;serotonergic synapse;ovarian steroidogenesis;oxytocin signaling pathway;regulation of lipolysis in adipocytes;leishmaniasis;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;pathways in cancer;chemical carcinogenesis;micrornas in cancer;small cell lung cancer
bromfenac,PTGS1,5,hsa00590;hsa01100;hsa04611;hsa04726;hsa04923,arachidonic acid metabolism;metabolic pathways;platelet activation;serotonergic synapse;regulation of lipolysis in adipocytes
testosterone,AR,3,hsa04114;hsa05200;hsa05215,oocyte meiosis;pathways in cancer;prostate cancer
testosterone,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
testosterone,NR3C2,1,hsa04960,aldosterone-regulated sodium reabsorption
hydroxychloroquine,TLR7,3,hsa04620;hsa05162;hsa05164,toll-like receptor signaling pathway;measles;influenza a
hydroxychloroquine,TLR9,8,hsa04620;hsa05142;hsa05143;hsa05144;hsa05152;hsa05162;hsa05168;hsa05235,toll-like receptor signaling pathway;chagas disease ;african trypanosomiasis;malaria;tuberculosis;measles;herpes simplex virus 1 infection;pd-l1 expression and pd-1 checkpoint pathway in cancer
hydroxychloroquine,ACE2,2,hsa04614;hsa04974,renin-angiotensin system;protein digestion and absorption
daunorubicin,TOP2A,1,hsa01524,platinum drug resistance
daunorubicin,TOP2B,1,hsa01524,platinum drug resistance
pd-0325901,MAP2K1,84,hsa01521;hsa01522;hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04114;hsa04140;hsa04150;hsa04151;hsa04210;hsa04218;hsa04270;hsa04370;hsa04371;hsa04380;hsa04510;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04720;hsa04722;hsa04725;hsa04726;hsa04730;hsa04810;hsa04910;hsa04912;hsa04914;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04926;hsa04928;hsa04929;hsa04934;hsa04935;hsa05020;hsa05034;hsa05135;hsa05160;hsa05161;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;mapk signaling pathway;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;oocyte meiosis;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;apoptosis;cellular senescence;vascular smooth muscle contraction;vegf signaling pathway;apelin signaling pathway;osteoclast differentiation;focal adhesion;gap junction;signaling pathways regulating pluripotency of stem cells;toll-like receptor signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;long-term potentiation;neurotrophin signaling pathway;cholinergic synapse;serotonergic synapse;long-term depression;regulation of actin cytoskeleton;insulin signaling pathway;gnrh signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;parathyroid hormone synthesis, secretion and action;gnrh secretion;cushing syndrome;growth hormone synthesis, secretion and action;prion diseases;alcoholism;yersinia infection;hepatitis c;hepatitis b;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;thyroid cancer;melanoma;bladder cancer;chronic myeloid leukemia;acute myeloid leukemia;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
zidovudine,TERT,5,hsa05165;hsa05166;hsa05200;hsa05225;hsa05226,human papillomavirus infection;human t-cell leukemia virus 1 infection;pathways in cancer;hepatocellular carcinoma;gastric cancer
ag-14361,PARP1,4,hsa03410;hsa04064;hsa04210;hsa04217,base excision repair;nf-kappa b signaling pathway;apoptosis;necroptosis
nvp-bez235,ATR,7,hsa03460;hsa04110;hsa04115;hsa04218;hsa05165;hsa05166;hsa05170,fanconi anemia pathway;cell cycle;p53 signaling pathway;cellular senescence;human papillomavirus infection;human t-cell leukemia virus 1 infection;human immunodeficiency virus 1 infection
nvp-bez235,MTOR,44,hsa01521;hsa01522;hsa04012;hsa04066;hsa04072;hsa04136;hsa04140;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04218;hsa04371;hsa04630;hsa04659;hsa04714;hsa04910;hsa04919;hsa04920;hsa04930;hsa04931;hsa04935;hsa05017;hsa05131;hsa05163;hsa05165;hsa05167;hsa05168;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05212;hsa05214;hsa05215;hsa05221;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;hif-1 signaling pathway;phospholipase d signaling pathway;autophagy - other;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;apelin signaling pathway;jak-stat signaling pathway;th17 cell differentiation;thermogenesis;insulin signaling pathway;thyroid hormone signaling pathway;adipocytokine signaling pathway;type ii diabetes mellitus;insulin resistance;growth hormone synthesis, secretion and action;spinocerebellar ataxia;shigellosis;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;pancreatic cancer;glioma;prostate cancer;acute myeloid leukemia;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
nvp-bez235,PIK3CA,97,hsa00562;hsa01100;hsa01521;hsa01522;hsa01524;hsa04012;hsa04014;hsa04015;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04218;hsa04360;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04625;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04923;hsa04926;hsa04929;hsa04930;hsa04931;hsa04932;hsa04933;hsa04935;hsa04960;hsa04973;hsa05017;hsa05100;hsa05131;hsa05135;hsa05142;hsa05146;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235;hsa05418,"inositol phosphate metabolism;metabolic pathways;egfr tyrosine kinase inhibitor resistance;endocrine resistance;platinum drug resistance;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phosphatidylinositol signaling system;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;axon guidance;vegf signaling pathway;osteoclast differentiation;focal adhesion;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;c-type lectin receptor signaling pathway;jak-stat signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;leukocyte transendothelial migration;neurotrophin signaling pathway;cholinergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;insulin signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;regulation of lipolysis in adipocytes;relaxin signaling pathway;gnrh secretion;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;aldosterone-regulated sodium reabsorption;carbohydrate digestion and absorption;spinocerebellar ataxia;bacterial invasion of epithelial cells;shigellosis;yersinia infection;chagas disease ;amoebiasis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;melanoma;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
nvp-bez235,PIK3CD,97,hsa00562;hsa01100;hsa01521;hsa01522;hsa01524;hsa04012;hsa04014;hsa04015;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04218;hsa04360;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04625;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04923;hsa04926;hsa04929;hsa04930;hsa04931;hsa04932;hsa04933;hsa04935;hsa04960;hsa04973;hsa05017;hsa05100;hsa05131;hsa05135;hsa05142;hsa05146;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235;hsa05418,"inositol phosphate metabolism;metabolic pathways;egfr tyrosine kinase inhibitor resistance;endocrine resistance;platinum drug resistance;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phosphatidylinositol signaling system;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;axon guidance;vegf signaling pathway;osteoclast differentiation;focal adhesion;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;c-type lectin receptor signaling pathway;jak-stat signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;leukocyte transendothelial migration;neurotrophin signaling pathway;cholinergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;insulin signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;regulation of lipolysis in adipocytes;relaxin signaling pathway;gnrh secretion;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;aldosterone-regulated sodium reabsorption;carbohydrate digestion and absorption;spinocerebellar ataxia;bacterial invasion of epithelial cells;shigellosis;yersinia infection;chagas disease ;amoebiasis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;melanoma;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
nvp-bez235,PIK3CG,13,hsa00562;hsa01100;hsa04022;hsa04062;hsa04072;hsa04151;hsa04261;hsa04371;hsa04611;hsa04725;hsa04921;hsa05145;hsa05167,inositol phosphate metabolism;metabolic pathways;cgmp-pkg signaling pathway;chemokine signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;adrenergic signaling in cardiomyocytes;apelin signaling pathway;platelet activation;cholinergic synapse;oxytocin signaling pathway;toxoplasmosis;kaposi sarcoma-associated herpesvirus infection
zileuton,ALOX5,6,hsa00590;hsa01100;hsa04664;hsa04726;hsa04913;hsa05145,arachidonic acid metabolism;metabolic pathways;fc epsilon ri signaling pathway;serotonergic synapse;ovarian steroidogenesis;toxoplasmosis
staurosporine,CHRM1,6,hsa04020;hsa04024;hsa04080;hsa04151;hsa04725;hsa04810,calcium signaling pathway;camp signaling pathway;neuroactive ligand-receptor interaction;pi3k-akt signaling pathway;cholinergic synapse;regulation of actin cytoskeleton
staurosporine,LCK,10,hsa04064;hsa04380;hsa04650;hsa04658;hsa04659;hsa04660;hsa05135;hsa05166;hsa05235;hsa05340,nf-kappa b signaling pathway;osteoclast differentiation;natural killer cell mediated cytotoxicity;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;yersinia infection;human t-cell leukemia virus 1 infection;pd-l1 expression and pd-1 checkpoint pathway in cancer;primary immunodeficiency
staurosporine,GSK3B,41,hsa01521;hsa04012;hsa04062;hsa04110;hsa04150;hsa04151;hsa04310;hsa04340;hsa04360;hsa04390;hsa04510;hsa04550;hsa04657;hsa04660;hsa04662;hsa04722;hsa04728;hsa04910;hsa04916;hsa04917;hsa04919;hsa04931;hsa04932;hsa04934;hsa04935;hsa05010;hsa05131;hsa05135;hsa05160;hsa05162;hsa05163;hsa05165;hsa05167;hsa05200;hsa05210;hsa05213;hsa05215;hsa05217;hsa05224;hsa05225;hsa05226,"egfr tyrosine kinase inhibitor resistance;erbb signaling pathway;chemokine signaling pathway;cell cycle;mtor signaling pathway;pi3k-akt signaling pathway;wnt signaling pathway;hedgehog signaling pathway;axon guidance;hippo signaling pathway;focal adhesion;signaling pathways regulating pluripotency of stem cells;il-17 signaling pathway;t cell receptor signaling pathway;b cell receptor signaling pathway;neurotrophin signaling pathway;dopaminergic synapse;insulin signaling pathway;melanogenesis;prolactin signaling pathway;thyroid hormone signaling pathway;insulin resistance;non-alcoholic fatty liver disease ;cushing syndrome;growth hormone synthesis, secretion and action;alzheimer disease;shigellosis;yersinia infection;hepatitis c;measles;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;pathways in cancer;colorectal cancer;endometrial cancer;prostate cancer;basal cell carcinoma;breast cancer;hepatocellular carcinoma;gastric cancer"
staurosporine,CDK2,19,hsa04068;hsa04110;hsa04114;hsa04115;hsa04151;hsa04218;hsa04914;hsa04934;hsa05160;hsa05161;hsa05162;hsa05165;hsa05166;hsa05169;hsa05200;hsa05203;hsa05215;hsa05222;hsa05226,foxo signaling pathway;cell cycle;oocyte meiosis;p53 signaling pathway;pi3k-akt signaling pathway;cellular senescence;progesterone-mediated oocyte maturation;cushing syndrome;hepatitis c;hepatitis b;measles;human papillomavirus infection;human t-cell leukemia virus 1 infection;epstein-barr virus infection;pathways in cancer;viral carcinogenesis;prostate cancer;small cell lung cancer;gastric cancer
staurosporine,PDPK1,23,hsa01524;hsa03320;hsa04068;hsa04071;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04510;hsa04660;hsa04664;hsa04722;hsa04910;hsa04919;hsa04931;hsa04960;hsa05145;hsa05205;hsa05213;hsa05215;hsa05223;hsa05231,platinum drug resistance;ppar signaling pathway;foxo signaling pathway;sphingolipid signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;focal adhesion;t cell receptor signaling pathway;fc epsilon ri signaling pathway;neurotrophin signaling pathway;insulin signaling pathway;thyroid hormone signaling pathway;insulin resistance;aldosterone-regulated sodium reabsorption;toxoplasmosis;proteoglycans in cancer;endometrial cancer;prostate cancer;non-small cell lung cancer;choline metabolism in cancer
staurosporine,PIM1,5,hsa04630;hsa04933;hsa05200;hsa05206;hsa05221,jak-stat signaling pathway;age-rage signaling pathway in diabetic complications;pathways in cancer;micrornas in cancer;acute myeloid leukemia
staurosporine,ZAP70,9,hsa04014;hsa04064;hsa04650;hsa04658;hsa04659;hsa04660;hsa05135;hsa05235;hsa05340,ras signaling pathway;nf-kappa b signaling pathway;natural killer cell mediated cytotoxicity;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;yersinia infection;pd-l1 expression and pd-1 checkpoint pathway in cancer;primary immunodeficiency
staurosporine,PIK3CG,13,hsa00562;hsa01100;hsa04022;hsa04062;hsa04072;hsa04151;hsa04261;hsa04371;hsa04611;hsa04725;hsa04921;hsa05145;hsa05167,inositol phosphate metabolism;metabolic pathways;cgmp-pkg signaling pathway;chemokine signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;adrenergic signaling in cardiomyocytes;apelin signaling pathway;platelet activation;cholinergic synapse;oxytocin signaling pathway;toxoplasmosis;kaposi sarcoma-associated herpesvirus infection
staurosporine,SYK,15,hsa04064;hsa04072;hsa04151;hsa04380;hsa04611;hsa04625;hsa04650;hsa04662;hsa04664;hsa04666;hsa05152;hsa05167;hsa05168;hsa05169;hsa05203,nf-kappa b signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;osteoclast differentiation;platelet activation;c-type lectin receptor signaling pathway;natural killer cell mediated cytotoxicity;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tuberculosis;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;viral carcinogenesis
staurosporine,ITK,3,hsa04062;hsa04660;hsa04670,chemokine signaling pathway;t cell receptor signaling pathway;leukocyte transendothelial migration
staurosporine,CSK,1,hsa05120,epithelial cell signaling in helicobacter pylori infection
staurosporine,MAPKAPK2,7,hsa04010;hsa04218;hsa04370;hsa04625;hsa04722;hsa05167;hsa05203,mapk signaling pathway;cellular senescence;vegf signaling pathway;c-type lectin receptor signaling pathway;neurotrophin signaling pathway;kaposi sarcoma-associated herpesvirus infection;viral carcinogenesis
staurosporine,PRKCQ,11,hsa04064;hsa04140;hsa04270;hsa04658;hsa04659;hsa04660;hsa04750;hsa04920;hsa04931;hsa05131;hsa05235,nf-kappa b signaling pathway;autophagy - animal;vascular smooth muscle contraction;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;inflammatory mediator regulation of trp channels;adipocytokine signaling pathway;insulin resistance;shigellosis;pd-l1 expression and pd-1 checkpoint pathway in cancer
fasudil,PKIA,1,hsa05034,alcoholism
fasudil,PRKACA,69,hsa01522;hsa04010;hsa04014;hsa04020;hsa04024;hsa04062;hsa04114;hsa04140;hsa04211;hsa04213;hsa04261;hsa04270;hsa04310;hsa04340;hsa04371;hsa04530;hsa04540;hsa04611;hsa04713;hsa04714;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04740;hsa04742;hsa04750;hsa04910;hsa04911;hsa04912;hsa04913;hsa04914;hsa04915;hsa04916;hsa04918;hsa04919;hsa04921;hsa04922;hsa04923;hsa04924;hsa04925;hsa04926;hsa04927;hsa04928;hsa04934;hsa04935;hsa04961;hsa04962;hsa04970;hsa04971;hsa04976;hsa05012;hsa05020;hsa05030;hsa05031;hsa05032;hsa05034;hsa05110;hsa05146;hsa05163;hsa05165;hsa05166;hsa05200;hsa05203;hsa05205;hsa05414,"endocrine resistance;mapk signaling pathway;ras signaling pathway;calcium signaling pathway;camp signaling pathway;chemokine signaling pathway;oocyte meiosis;autophagy - animal;longevity regulating pathway;longevity regulating pathway - multiple species;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;wnt signaling pathway;hedgehog signaling pathway;apelin signaling pathway;tight junction;gap junction;platelet activation;circadian entrainment;thermogenesis;long-term potentiation;retrograde endocannabinoid signaling;glutamatergic synapse;cholinergic synapse;serotonergic synapse;gabaergic synapse;dopaminergic synapse;olfactory transduction;taste transduction;inflammatory mediator regulation of trp channels;insulin signaling pathway;insulin secretion;gnrh signaling pathway;ovarian steroidogenesis;progesterone-mediated oocyte maturation;estrogen signaling pathway;melanogenesis;thyroid hormone synthesis;thyroid hormone signaling pathway;oxytocin signaling pathway;glucagon signaling pathway;regulation of lipolysis in adipocytes;renin secretion;aldosterone synthesis and secretion;relaxin signaling pathway;cortisol synthesis and secretion;parathyroid hormone synthesis, secretion and action;cushing syndrome;growth hormone synthesis, secretion and action;endocrine and other factor-regulated calcium reabsorption;vasopressin-regulated water reabsorption;salivary secretion;gastric acid secretion;bile secretion;parkinson disease;prion diseases;cocaine addiction;amphetamine addiction;morphine addiction;alcoholism;vibrio cholerae infection;amoebiasis;human cytomegalovirus infection;human papillomavirus infection;human t-cell leukemia virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;dilated cardiomyopathy "
fasudil,ROCK1,21,hsa04022;hsa04024;hsa04062;hsa04071;hsa04270;hsa04350;hsa04360;hsa04510;hsa04530;hsa04611;hsa04670;hsa04810;hsa04921;hsa05130;hsa05131;hsa05132;hsa05135;hsa05163;hsa05200;hsa05205;hsa05206,cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;sphingolipid signaling pathway;vascular smooth muscle contraction;tgf-beta signaling pathway;axon guidance;focal adhesion;tight junction;platelet activation;leukocyte transendothelial migration;regulation of actin cytoskeleton;oxytocin signaling pathway;pathogenic escherichia coli infection;shigellosis;salmonella infection;yersinia infection;human cytomegalovirus infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer
fasudil,ROCK2,20,hsa04022;hsa04024;hsa04062;hsa04071;hsa04270;hsa04310;hsa04360;hsa04510;hsa04530;hsa04611;hsa04670;hsa04810;hsa04921;hsa05130;hsa05131;hsa05132;hsa05135;hsa05163;hsa05200;hsa05205,cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;sphingolipid signaling pathway;vascular smooth muscle contraction;wnt signaling pathway;axon guidance;focal adhesion;tight junction;platelet activation;leukocyte transendothelial migration;regulation of actin cytoskeleton;oxytocin signaling pathway;pathogenic escherichia coli infection;shigellosis;salmonella infection;yersinia infection;human cytomegalovirus infection;pathways in cancer;proteoglycans in cancer
gsk-1059615,PIK3CG,13,hsa00562;hsa01100;hsa04022;hsa04062;hsa04072;hsa04151;hsa04261;hsa04371;hsa04611;hsa04725;hsa04921;hsa05145;hsa05167,inositol phosphate metabolism;metabolic pathways;cgmp-pkg signaling pathway;chemokine signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;adrenergic signaling in cardiomyocytes;apelin signaling pathway;platelet activation;cholinergic synapse;oxytocin signaling pathway;toxoplasmosis;kaposi sarcoma-associated herpesvirus infection
pi 103 hydrochloride,MTOR,44,hsa01521;hsa01522;hsa04012;hsa04066;hsa04072;hsa04136;hsa04140;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04218;hsa04371;hsa04630;hsa04659;hsa04714;hsa04910;hsa04919;hsa04920;hsa04930;hsa04931;hsa04935;hsa05017;hsa05131;hsa05163;hsa05165;hsa05167;hsa05168;hsa05170;hsa05200;hsa05205;hsa05206;hsa05210;hsa05212;hsa05214;hsa05215;hsa05221;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235,"egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;hif-1 signaling pathway;phospholipase d signaling pathway;autophagy - other;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;apelin signaling pathway;jak-stat signaling pathway;th17 cell differentiation;thermogenesis;insulin signaling pathway;thyroid hormone signaling pathway;adipocytokine signaling pathway;type ii diabetes mellitus;insulin resistance;growth hormone synthesis, secretion and action;spinocerebellar ataxia;shigellosis;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;human immunodeficiency virus 1 infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer;colorectal cancer;pancreatic cancer;glioma;prostate cancer;acute myeloid leukemia;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer"
pi 103 hydrochloride,PIK3CA,97,hsa00562;hsa01100;hsa01521;hsa01522;hsa01524;hsa04012;hsa04014;hsa04015;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04218;hsa04360;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04625;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04923;hsa04926;hsa04929;hsa04930;hsa04931;hsa04932;hsa04933;hsa04935;hsa04960;hsa04973;hsa05017;hsa05100;hsa05131;hsa05135;hsa05142;hsa05146;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235;hsa05418,"inositol phosphate metabolism;metabolic pathways;egfr tyrosine kinase inhibitor resistance;endocrine resistance;platinum drug resistance;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phosphatidylinositol signaling system;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;axon guidance;vegf signaling pathway;osteoclast differentiation;focal adhesion;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;c-type lectin receptor signaling pathway;jak-stat signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;leukocyte transendothelial migration;neurotrophin signaling pathway;cholinergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;insulin signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;regulation of lipolysis in adipocytes;relaxin signaling pathway;gnrh secretion;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;aldosterone-regulated sodium reabsorption;carbohydrate digestion and absorption;spinocerebellar ataxia;bacterial invasion of epithelial cells;shigellosis;yersinia infection;chagas disease ;amoebiasis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;melanoma;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
pi 103 hydrochloride,PIK3CB,97,hsa00562;hsa01100;hsa01521;hsa01522;hsa01524;hsa04012;hsa04014;hsa04015;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04218;hsa04360;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04625;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04923;hsa04926;hsa04929;hsa04930;hsa04931;hsa04932;hsa04933;hsa04935;hsa04960;hsa04973;hsa05017;hsa05100;hsa05131;hsa05135;hsa05142;hsa05146;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235;hsa05418,"inositol phosphate metabolism;metabolic pathways;egfr tyrosine kinase inhibitor resistance;endocrine resistance;platinum drug resistance;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phosphatidylinositol signaling system;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;axon guidance;vegf signaling pathway;osteoclast differentiation;focal adhesion;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;c-type lectin receptor signaling pathway;jak-stat signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;leukocyte transendothelial migration;neurotrophin signaling pathway;cholinergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;insulin signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;regulation of lipolysis in adipocytes;relaxin signaling pathway;gnrh secretion;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;aldosterone-regulated sodium reabsorption;carbohydrate digestion and absorption;spinocerebellar ataxia;bacterial invasion of epithelial cells;shigellosis;yersinia infection;chagas disease ;amoebiasis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;melanoma;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
pi 103 hydrochloride,PIK3CD,97,hsa00562;hsa01100;hsa01521;hsa01522;hsa01524;hsa04012;hsa04014;hsa04015;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04140;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04218;hsa04360;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04625;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04923;hsa04926;hsa04929;hsa04930;hsa04931;hsa04932;hsa04933;hsa04935;hsa04960;hsa04973;hsa05017;hsa05100;hsa05131;hsa05135;hsa05142;hsa05146;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05224;hsa05225;hsa05226;hsa05230;hsa05231;hsa05235;hsa05418,"inositol phosphate metabolism;metabolic pathways;egfr tyrosine kinase inhibitor resistance;endocrine resistance;platinum drug resistance;erbb signaling pathway;ras signaling pathway;rap1 signaling pathway;camp signaling pathway;chemokine signaling pathway;hif-1 signaling pathway;foxo signaling pathway;phosphatidylinositol signaling system;sphingolipid signaling pathway;phospholipase d signaling pathway;autophagy - animal;mtor signaling pathway;pi3k-akt signaling pathway;ampk signaling pathway;apoptosis;longevity regulating pathway;longevity regulating pathway - multiple species;cellular senescence;axon guidance;vegf signaling pathway;osteoclast differentiation;focal adhesion;signaling pathways regulating pluripotency of stem cells;platelet activation;toll-like receptor signaling pathway;c-type lectin receptor signaling pathway;jak-stat signaling pathway;natural killer cell mediated cytotoxicity;t cell receptor signaling pathway;b cell receptor signaling pathway;fc epsilon ri signaling pathway;fc gamma r-mediated phagocytosis;tnf signaling pathway;leukocyte transendothelial migration;neurotrophin signaling pathway;cholinergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;insulin signaling pathway;progesterone-mediated oocyte maturation;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;regulation of lipolysis in adipocytes;relaxin signaling pathway;gnrh secretion;type ii diabetes mellitus;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;growth hormone synthesis, secretion and action;aldosterone-regulated sodium reabsorption;carbohydrate digestion and absorption;spinocerebellar ataxia;bacterial invasion of epithelial cells;shigellosis;yersinia infection;chagas disease ;amoebiasis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;micrornas in cancer;colorectal cancer;renal cell carcinoma;pancreatic cancer;endometrial cancer;glioma;prostate cancer;melanoma;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;non-small cell lung cancer;breast cancer;hepatocellular carcinoma;gastric cancer;central carbon metabolism in cancer;choline metabolism in cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;fluid shear stress and atherosclerosis"
pi 103 hydrochloride,PIK3CG,13,hsa00562;hsa01100;hsa04022;hsa04062;hsa04072;hsa04151;hsa04261;hsa04371;hsa04611;hsa04725;hsa04921;hsa05145;hsa05167,inositol phosphate metabolism;metabolic pathways;cgmp-pkg signaling pathway;chemokine signaling pathway;phospholipase d signaling pathway;pi3k-akt signaling pathway;adrenergic signaling in cardiomyocytes;apelin signaling pathway;platelet activation;cholinergic synapse;oxytocin signaling pathway;toxoplasmosis;kaposi sarcoma-associated herpesvirus infection
pi 103 hydrochloride,PRKDC,2,hsa03450;hsa04110,non-homologous end-joining;cell cycle
hexachlorophene,SDHD,9,hsa00020;hsa00190;hsa01100;hsa01200;hsa04714;hsa04932;hsa05010;hsa05012;hsa05016,citrate cycle ;oxidative phosphorylation;metabolic pathways;carbon metabolism;thermogenesis;non-alcoholic fatty liver disease ;alzheimer disease;parkinson disease;huntington disease
hexachlorophene,GLUD1,8,hsa00220;hsa00250;hsa00471;hsa00910;hsa01100;hsa01200;hsa04217;hsa04964,"arginine biosynthesis;alanine, aspartate and glutamate metabolism;d-glutamine and d-glutamate metabolism;nitrogen metabolism;metabolic pathways;carbon metabolism;necroptosis;proximal tubule bicarbonate reclamation"
hexachlorophene,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
ofloxacin,TOP2A,1,hsa01524,platinum drug resistance
leflunomide,DHODH,2,hsa00240;hsa01100,pyrimidine metabolism;metabolic pathways
leflunomide,AHR,2,hsa04659;hsa04934,th17 cell differentiation;cushing syndrome
leflunomide,PTK2B,10,hsa04020;hsa04062;hsa04072;hsa04650;hsa04670;hsa04912;hsa05135;hsa05161;hsa05163;hsa05170,calcium signaling pathway;chemokine signaling pathway;phospholipase d signaling pathway;natural killer cell mediated cytotoxicity;leukocyte transendothelial migration;gnrh signaling pathway;yersinia infection;hepatitis b;human cytomegalovirus infection;human immunodeficiency virus 1 infection
prasterone,ESR2,6,hsa01522;hsa04915;hsa04917;hsa04929;hsa05200;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;gnrh secretion;pathways in cancer;breast cancer
prasterone,ESR1,8,hsa01522;hsa04915;hsa04917;hsa04919;hsa04961;hsa05200;hsa05205;hsa05224,endocrine resistance;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;endocrine and other factor-regulated calcium reabsorption;pathways in cancer;proteoglycans in cancer;breast cancer
prasterone,AR,3,hsa04114;hsa05200;hsa05215,oocyte meiosis;pathways in cancer;prostate cancer
prasterone,PPARA,7,hsa03320;hsa04024;hsa04920;hsa04922;hsa04931;hsa04932;hsa05160,ppar signaling pathway;camp signaling pathway;adipocytokine signaling pathway;glucagon signaling pathway;insulin resistance;non-alcoholic fatty liver disease ;hepatitis c
prasterone,SIGMAR1,0,,
prasterone,NR1I2,0,,
prasterone,NR1I3,0,,
n-(2-aminoethyl)-1-aziridineethanamine,ACE2,2,hsa04614;hsa04974,renin-angiotensin system;protein digestion and absorption
triptolide,RELA,67,hsa01523;hsa04010;hsa04014;hsa04024;hsa04062;hsa04064;hsa04066;hsa04071;hsa04137;hsa04151;hsa04210;hsa04211;hsa04218;hsa04380;hsa04620;hsa04621;hsa04622;hsa04623;hsa04625;hsa04657;hsa04658;hsa04659;hsa04660;hsa04662;hsa04668;hsa04722;hsa04917;hsa04920;hsa04926;hsa04931;hsa04932;hsa04933;hsa05030;hsa05120;hsa05130;hsa05131;hsa05132;hsa05133;hsa05134;hsa05135;hsa05140;hsa05142;hsa05145;hsa05146;hsa05152;hsa05160;hsa05161;hsa05162;hsa05163;hsa05164;hsa05165;hsa05166;hsa05167;hsa05168;hsa05169;hsa05170;hsa05200;hsa05202;hsa05203;hsa05212;hsa05215;hsa05220;hsa05221;hsa05222;hsa05235;hsa05321;hsa05418,antifolate resistance;mapk signaling pathway;ras signaling pathway;camp signaling pathway;chemokine signaling pathway;nf-kappa b signaling pathway;hif-1 signaling pathway;sphingolipid signaling pathway;mitophagy - animal;pi3k-akt signaling pathway;apoptosis;longevity regulating pathway;cellular senescence;osteoclast differentiation;toll-like receptor signaling pathway;nod-like receptor signaling pathway;rig-i-like receptor signaling pathway;cytosolic dna-sensing pathway;c-type lectin receptor signaling pathway;il-17 signaling pathway;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;b cell receptor signaling pathway;tnf signaling pathway;neurotrophin signaling pathway;prolactin signaling pathway;adipocytokine signaling pathway;relaxin signaling pathway;insulin resistance;non-alcoholic fatty liver disease ;age-rage signaling pathway in diabetic complications;cocaine addiction;epithelial cell signaling in helicobacter pylori infection;pathogenic escherichia coli infection;shigellosis;salmonella infection;pertussis;legionellosis;yersinia infection;leishmaniasis;chagas disease ;toxoplasmosis;amoebiasis;tuberculosis;hepatitis c;hepatitis b;measles;human cytomegalovirus infection;influenza a;human papillomavirus infection;human t-cell leukemia virus 1 infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;pancreatic cancer;prostate cancer;chronic myeloid leukemia;acute myeloid leukemia;small cell lung cancer;pd-l1 expression and pd-1 checkpoint pathway in cancer;inflammatory bowel disease ;fluid shear stress and atherosclerosis
y-27632,PRKACA,69,hsa01522;hsa04010;hsa04014;hsa04020;hsa04024;hsa04062;hsa04114;hsa04140;hsa04211;hsa04213;hsa04261;hsa04270;hsa04310;hsa04340;hsa04371;hsa04530;hsa04540;hsa04611;hsa04713;hsa04714;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04740;hsa04742;hsa04750;hsa04910;hsa04911;hsa04912;hsa04913;hsa04914;hsa04915;hsa04916;hsa04918;hsa04919;hsa04921;hsa04922;hsa04923;hsa04924;hsa04925;hsa04926;hsa04927;hsa04928;hsa04934;hsa04935;hsa04961;hsa04962;hsa04970;hsa04971;hsa04976;hsa05012;hsa05020;hsa05030;hsa05031;hsa05032;hsa05034;hsa05110;hsa05146;hsa05163;hsa05165;hsa05166;hsa05200;hsa05203;hsa05205;hsa05414,"endocrine resistance;mapk signaling pathway;ras signaling pathway;calcium signaling pathway;camp signaling pathway;chemokine signaling pathway;oocyte meiosis;autophagy - animal;longevity regulating pathway;longevity regulating pathway - multiple species;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;wnt signaling pathway;hedgehog signaling pathway;apelin signaling pathway;tight junction;gap junction;platelet activation;circadian entrainment;thermogenesis;long-term potentiation;retrograde endocannabinoid signaling;glutamatergic synapse;cholinergic synapse;serotonergic synapse;gabaergic synapse;dopaminergic synapse;olfactory transduction;taste transduction;inflammatory mediator regulation of trp channels;insulin signaling pathway;insulin secretion;gnrh signaling pathway;ovarian steroidogenesis;progesterone-mediated oocyte maturation;estrogen signaling pathway;melanogenesis;thyroid hormone synthesis;thyroid hormone signaling pathway;oxytocin signaling pathway;glucagon signaling pathway;regulation of lipolysis in adipocytes;renin secretion;aldosterone synthesis and secretion;relaxin signaling pathway;cortisol synthesis and secretion;parathyroid hormone synthesis, secretion and action;cushing syndrome;growth hormone synthesis, secretion and action;endocrine and other factor-regulated calcium reabsorption;vasopressin-regulated water reabsorption;salivary secretion;gastric acid secretion;bile secretion;parkinson disease;prion diseases;cocaine addiction;amphetamine addiction;morphine addiction;alcoholism;vibrio cholerae infection;amoebiasis;human cytomegalovirus infection;human papillomavirus infection;human t-cell leukemia virus 1 infection;pathways in cancer;viral carcinogenesis;proteoglycans in cancer;dilated cardiomyopathy "
y-27632,PKIA,1,hsa05034,alcoholism
y-27632,ROCK1,21,hsa04022;hsa04024;hsa04062;hsa04071;hsa04270;hsa04350;hsa04360;hsa04510;hsa04530;hsa04611;hsa04670;hsa04810;hsa04921;hsa05130;hsa05131;hsa05132;hsa05135;hsa05163;hsa05200;hsa05205;hsa05206,cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;sphingolipid signaling pathway;vascular smooth muscle contraction;tgf-beta signaling pathway;axon guidance;focal adhesion;tight junction;platelet activation;leukocyte transendothelial migration;regulation of actin cytoskeleton;oxytocin signaling pathway;pathogenic escherichia coli infection;shigellosis;salmonella infection;yersinia infection;human cytomegalovirus infection;pathways in cancer;proteoglycans in cancer;micrornas in cancer
y-27632,ROCK2,20,hsa04022;hsa04024;hsa04062;hsa04071;hsa04270;hsa04310;hsa04360;hsa04510;hsa04530;hsa04611;hsa04670;hsa04810;hsa04921;hsa05130;hsa05131;hsa05132;hsa05135;hsa05163;hsa05200;hsa05205,cgmp-pkg signaling pathway;camp signaling pathway;chemokine signaling pathway;sphingolipid signaling pathway;vascular smooth muscle contraction;wnt signaling pathway;axon guidance;focal adhesion;tight junction;platelet activation;leukocyte transendothelial migration;regulation of actin cytoskeleton;oxytocin signaling pathway;pathogenic escherichia coli infection;shigellosis;salmonella infection;yersinia infection;human cytomegalovirus infection;pathways in cancer;proteoglycans in cancer
saracatinib,ABL1,11,hsa04012;hsa04014;hsa04110;hsa04360;hsa04722;hsa05130;hsa05131;hsa05200;hsa05206;hsa05220;hsa05416,erbb signaling pathway;ras signaling pathway;cell cycle;axon guidance;neurotrophin signaling pathway;pathogenic escherichia coli infection;shigellosis;pathways in cancer;micrornas in cancer;chronic myeloid leukemia;viral myocarditis
saracatinib,LCK,10,hsa04064;hsa04380;hsa04650;hsa04658;hsa04659;hsa04660;hsa05135;hsa05166;hsa05235;hsa05340,nf-kappa b signaling pathway;osteoclast differentiation;natural killer cell mediated cytotoxicity;th1 and th2 cell differentiation;th17 cell differentiation;t cell receptor signaling pathway;yersinia infection;human t-cell leukemia virus 1 infection;pd-l1 expression and pd-1 checkpoint pathway in cancer;primary immunodeficiency
saracatinib,SRC,37,hsa01521;hsa01522;hsa04012;hsa04015;hsa04062;hsa04137;hsa04144;hsa04360;hsa04370;hsa04510;hsa04520;hsa04530;hsa04540;hsa04611;hsa04625;hsa04727;hsa04750;hsa04810;hsa04912;hsa04915;hsa04917;hsa04919;hsa04921;hsa04926;hsa05100;hsa05120;hsa05131;hsa05135;hsa05152;hsa05161;hsa05163;hsa05167;hsa05168;hsa05203;hsa05205;hsa05219;hsa05418,egfr tyrosine kinase inhibitor resistance;endocrine resistance;erbb signaling pathway;rap1 signaling pathway;chemokine signaling pathway;mitophagy - animal;endocytosis;axon guidance;vegf signaling pathway;focal adhesion;adherens junction;tight junction;gap junction;platelet activation;c-type lectin receptor signaling pathway;gabaergic synapse;inflammatory mediator regulation of trp channels;regulation of actin cytoskeleton;gnrh signaling pathway;estrogen signaling pathway;prolactin signaling pathway;thyroid hormone signaling pathway;oxytocin signaling pathway;relaxin signaling pathway;bacterial invasion of epithelial cells;epithelial cell signaling in helicobacter pylori infection;shigellosis;yersinia infection;tuberculosis;hepatitis b;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;herpes simplex virus 1 infection;viral carcinogenesis;proteoglycans in cancer;bladder cancer;fluid shear stress and atherosclerosis
saracatinib,YES1,1,hsa04520,adherens junction
ly-255283,LTB4R,1,hsa04080,neuroactive ligand-receptor interaction
ly-255283,LTB4R2,2,hsa04020;hsa04080,calcium signaling pathway;neuroactive ligand-receptor interaction
rofecoxib,PTGS2,20,hsa00590;hsa01100;hsa04064;hsa04370;hsa04625;hsa04657;hsa04668;hsa04723;hsa04726;hsa04913;hsa04921;hsa04923;hsa05140;hsa05163;hsa05165;hsa05167;hsa05200;hsa05204;hsa05206;hsa05222,arachidonic acid metabolism;metabolic pathways;nf-kappa b signaling pathway;vegf signaling pathway;c-type lectin receptor signaling pathway;il-17 signaling pathway;tnf signaling pathway;retrograde endocannabinoid signaling;serotonergic synapse;ovarian steroidogenesis;oxytocin signaling pathway;regulation of lipolysis in adipocytes;leishmaniasis;human cytomegalovirus infection;human papillomavirus infection;kaposi sarcoma-associated herpesvirus infection;pathways in cancer;chemical carcinogenesis;micrornas in cancer;small cell lung cancer
rofecoxib,ELN,1,hsa04974,protein digestion and absorption
simvastatin,HMGCR,4,hsa00900;hsa01100;hsa04152;hsa04976,terpenoid backbone biosynthesis;metabolic pathways;ampk signaling pathway;bile secretion
simvastatin,ITGAL,11,hsa04015;hsa04514;hsa04650;hsa04670;hsa04810;hsa05144;hsa05150;hsa05166;hsa05169;hsa05323;hsa05416,rap1 signaling pathway;cell adhesion molecules ;natural killer cell mediated cytotoxicity;leukocyte transendothelial migration;regulation of actin cytoskeleton;malaria;staphylococcus aureus infection;human t-cell leukemia virus 1 infection;epstein-barr virus infection;rheumatoid arthritis;viral myocarditis
simvastatin,HDAC2,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
ebastine,CYP3A4,9,hsa00140;hsa00591;hsa00830;hsa00980;hsa00982;hsa00983;hsa01100;hsa04976;hsa05204,steroid hormone biosynthesis;linoleic acid metabolism;retinol metabolism;metabolism of xenobiotics by cytochrome p450;drug metabolism - cytochrome p450;drug metabolism - other enzymes;metabolic pathways;bile secretion;chemical carcinogenesis
ebastine,HRH1,3,hsa04020;hsa04080;hsa04750,calcium signaling pathway;neuroactive ligand-receptor interaction;inflammatory mediator regulation of trp channels
cisplatin,MPG,1,hsa03410,base excision repair
cisplatin,A2M,1,hsa04610,complement and coagulation cascades
cisplatin,TF,3,hsa04066;hsa04216;hsa04978,hif-1 signaling pathway;ferroptosis;mineral absorption
cisplatin,ATOX1,1,hsa04978,mineral absorption
hydroquinone,TYR,3,hsa00350;hsa01100;hsa04916,tyrosine metabolism;metabolic pathways;melanogenesis
calcium citrate,CALM1,40,hsa04014;hsa04015;hsa04020;hsa04022;hsa04024;hsa04070;hsa04114;hsa04218;hsa04261;hsa04270;hsa04371;hsa04625;hsa04713;hsa04720;hsa04722;hsa04728;hsa04740;hsa04744;hsa04750;hsa04910;hsa04912;hsa04915;hsa04916;hsa04921;hsa04922;hsa04924;hsa04925;hsa04970;hsa04971;hsa05010;hsa05031;hsa05034;hsa05133;hsa05152;hsa05163;hsa05167;hsa05170;hsa05200;hsa05214;hsa05418,ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;phosphatidylinositol signaling system;oocyte meiosis;cellular senescence;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;apelin signaling pathway;c-type lectin receptor signaling pathway;circadian entrainment;long-term potentiation;neurotrophin signaling pathway;dopaminergic synapse;olfactory transduction;phototransduction;inflammatory mediator regulation of trp channels;insulin signaling pathway;gnrh signaling pathway;estrogen signaling pathway;melanogenesis;oxytocin signaling pathway;glucagon signaling pathway;renin secretion;aldosterone synthesis and secretion;salivary secretion;gastric acid secretion;alzheimer disease;amphetamine addiction;alcoholism;pertussis;tuberculosis;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;glioma;fluid shear stress and atherosclerosis
calcium citrate,CASR,2,hsa04621;hsa04928,"nod-like receptor signaling pathway;parathyroid hormone synthesis, secretion and action"
calcium citrate,S100A13,0,,
calcium citrate,CANX,5,hsa04141;hsa04145;hsa04612;hsa04918;hsa05166,protein processing in endoplasmic reticulum;phagosome;antigen processing and presentation;thyroid hormone synthesis;human t-cell leukemia virus 1 infection
calcium citrate,S100B,0,,
calcium citrate,CALR,9,hsa04141;hsa04145;hsa04612;hsa05142;hsa05163;hsa05166;hsa05168;hsa05169;hsa05170,protein processing in endoplasmic reticulum;phagosome;antigen processing and presentation;chagas disease ;human cytomegalovirus infection;human t-cell leukemia virus 1 infection;herpes simplex virus 1 infection;epstein-barr virus infection;human immunodeficiency virus 1 infection
calcium citrate,SPARC,0,,
calcium citrate,S100A6,0,,
calcium citrate,NCS1,0,,
calcium citrate,RGN,4,hsa00030;hsa00053;hsa01100;hsa01200,pentose phosphate pathway;ascorbate and aldarate metabolism;metabolic pathways;carbon metabolism
calcium citrate,NRXN1,1,hsa04514,cell adhesion molecules 
calcium citrate,PDCD6,0,,
calcium citrate,CIB1,0,,
calcium citrate,SRI,0,,
calcium citrate,CHP1,0,,
calcium citrate,FBN2,0,,
calcium citrate,CASQ2,2,hsa04020;hsa04260,calcium signaling pathway;cardiac muscle contraction
calcium citrate,PEF1,0,,
calcium citrate,TPT1,0,,
calcium citrate,CIB2,0,,
calcium citrate,CASQ1,1,hsa04020,calcium signaling pathway
calcium citrate,NUCB1,0,,
calcium citrate,NUCB2,0,,
calcium citrate,FBN3,0,,
calcium citrate,GCA,0,,
calcium citrate,CADPS,0,,
calcium citrate,CALM2,40,hsa04014;hsa04015;hsa04020;hsa04022;hsa04024;hsa04070;hsa04114;hsa04218;hsa04261;hsa04270;hsa04371;hsa04625;hsa04713;hsa04720;hsa04722;hsa04728;hsa04740;hsa04744;hsa04750;hsa04910;hsa04912;hsa04915;hsa04916;hsa04921;hsa04922;hsa04924;hsa04925;hsa04970;hsa04971;hsa05010;hsa05031;hsa05034;hsa05133;hsa05152;hsa05163;hsa05167;hsa05170;hsa05200;hsa05214;hsa05418,ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;phosphatidylinositol signaling system;oocyte meiosis;cellular senescence;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;apelin signaling pathway;c-type lectin receptor signaling pathway;circadian entrainment;long-term potentiation;neurotrophin signaling pathway;dopaminergic synapse;olfactory transduction;phototransduction;inflammatory mediator regulation of trp channels;insulin signaling pathway;gnrh signaling pathway;estrogen signaling pathway;melanogenesis;oxytocin signaling pathway;glucagon signaling pathway;renin secretion;aldosterone synthesis and secretion;salivary secretion;gastric acid secretion;alzheimer disease;amphetamine addiction;alcoholism;pertussis;tuberculosis;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;glioma;fluid shear stress and atherosclerosis
calcium citrate,CALM3,40,hsa04014;hsa04015;hsa04020;hsa04022;hsa04024;hsa04070;hsa04114;hsa04218;hsa04261;hsa04270;hsa04371;hsa04625;hsa04713;hsa04720;hsa04722;hsa04728;hsa04740;hsa04744;hsa04750;hsa04910;hsa04912;hsa04915;hsa04916;hsa04921;hsa04922;hsa04924;hsa04925;hsa04970;hsa04971;hsa05010;hsa05031;hsa05034;hsa05133;hsa05152;hsa05163;hsa05167;hsa05170;hsa05200;hsa05214;hsa05418,ras signaling pathway;rap1 signaling pathway;calcium signaling pathway;cgmp-pkg signaling pathway;camp signaling pathway;phosphatidylinositol signaling system;oocyte meiosis;cellular senescence;adrenergic signaling in cardiomyocytes;vascular smooth muscle contraction;apelin signaling pathway;c-type lectin receptor signaling pathway;circadian entrainment;long-term potentiation;neurotrophin signaling pathway;dopaminergic synapse;olfactory transduction;phototransduction;inflammatory mediator regulation of trp channels;insulin signaling pathway;gnrh signaling pathway;estrogen signaling pathway;melanogenesis;oxytocin signaling pathway;glucagon signaling pathway;renin secretion;aldosterone synthesis and secretion;salivary secretion;gastric acid secretion;alzheimer disease;amphetamine addiction;alcoholism;pertussis;tuberculosis;human cytomegalovirus infection;kaposi sarcoma-associated herpesvirus infection;human immunodeficiency virus 1 infection;pathways in cancer;glioma;fluid shear stress and atherosclerosis
calcium citrate,S100A16,0,,
calcium citrate,CALB2,0,,
calcium citrate,CAPS,0,,
calcium citrate,CADPS2,0,,
calcium citrate,CALR3,0,,
jak3-inhibitor-i,JAK3,15,hsa04062;hsa04151;hsa04217;hsa04550;hsa04630;hsa04658;hsa04659;hsa05161;hsa05162;hsa05166;hsa05169;hsa05200;hsa05203;hsa05223;hsa05340,chemokine signaling pathway;pi3k-akt signaling pathway;necroptosis;signaling pathways regulating pluripotency of stem cells;jak-stat signaling pathway;th1 and th2 cell differentiation;th17 cell differentiation;hepatitis b;measles;human t-cell leukemia virus 1 infection;epstein-barr virus infection;pathways in cancer;viral carcinogenesis;non-small cell lung cancer;primary immunodeficiency
pracinostat,HDAC1,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
pracinostat,HDAC2,14,hsa04110;hsa04213;hsa04330;hsa04919;hsa05016;hsa05031;hsa05034;hsa05165;hsa05169;hsa05200;hsa05202;hsa05203;hsa05206;hsa05220,cell cycle;longevity regulating pathway - multiple species;notch signaling pathway;thyroid hormone signaling pathway;huntington disease;amphetamine addiction;alcoholism;human papillomavirus infection;epstein-barr virus infection;pathways in cancer;transcriptional misregulation in cancer;viral carcinogenesis;micrornas in cancer;chronic myeloid leukemia
pracinostat,HDAC3,3,hsa04919;hsa05034;hsa05203,thyroid hormone signaling pathway;alcoholism;viral carcinogenesis
pracinostat,HDAC6,2,hsa05034;hsa05203,alcoholism;viral carcinogenesis
blebbistatin,MYH14,3,hsa04530;hsa04810;hsa05130,tight junction;regulation of actin cytoskeleton;pathogenic escherichia coli infection
blebbistatin,MYH2,2,hsa04530;hsa05130,tight junction;pathogenic escherichia coli infection
pioglitazone,PPARG,9,hsa03320;hsa04152;hsa04211;hsa04380;hsa04714;hsa05016;hsa05200;hsa05202;hsa05216,ppar signaling pathway;ampk signaling pathway;longevity regulating pathway;osteoclast differentiation;thermogenesis;huntington disease;pathways in cancer;transcriptional misregulation in cancer;thyroid cancer
pioglitazone,MAOB,13,hsa00260;hsa00330;hsa00340;hsa00350;hsa00360;hsa00380;hsa00982;hsa01100;hsa04726;hsa04728;hsa05030;hsa05031;hsa05034,"glycine, serine and threonine metabolism;arginine and proline metabolism;histidine metabolism;tyrosine metabolism;phenylalanine metabolism;tryptophan metabolism;drug metabolism - cytochrome p450;metabolic pathways;serotonergic synapse;dopaminergic synapse;cocaine addiction;amphetamine addiction;alcoholism"
tegafur,TYMS,4,hsa00240;hsa00670;hsa01100;hsa01523,pyrimidine metabolism;one carbon pool by folate;metabolic pathways;antifolate resistance
choline salicylate,PCYT1B,4,hsa00440;hsa00564;hsa01100;hsa05231,phosphonate and phosphinate metabolism;glycerophospholipid metabolism;metabolic pathways;choline metabolism in cancer
choline salicylate,ACHE,2,hsa00564;hsa04725,glycerophospholipid metabolism;cholinergic synapse
choline salicylate,PCYT1A,4,hsa00440;hsa00564;hsa01100;hsa05231,phosphonate and phosphinate metabolism;glycerophospholipid metabolism;metabolic pathways;choline metabolism in cancer
choline salicylate,PLD2,15,hsa00564;hsa00565;hsa01100;hsa04014;hsa04024;hsa04071;hsa04072;hsa04144;hsa04666;hsa04724;hsa04912;hsa04928;hsa05200;hsa05212;hsa05231,"glycerophospholipid metabolism;ether lipid metabolism;metabolic pathways;ras signaling pathway;camp signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;endocytosis;fc gamma r-mediated phagocytosis;glutamatergic synapse;gnrh signaling pathway;parathyroid hormone synthesis, secretion and action;pathways in cancer;pancreatic cancer;choline metabolism in cancer"
choline salicylate,BCHE,0,,
choline salicylate,PLD1,15,hsa00564;hsa00565;hsa01100;hsa04014;hsa04024;hsa04071;hsa04072;hsa04144;hsa04666;hsa04724;hsa04912;hsa04928;hsa05200;hsa05212;hsa05231,"glycerophospholipid metabolism;ether lipid metabolism;metabolic pathways;ras signaling pathway;camp signaling pathway;sphingolipid signaling pathway;phospholipase d signaling pathway;endocytosis;fc gamma r-mediated phagocytosis;glutamatergic synapse;gnrh signaling pathway;parathyroid hormone synthesis, secretion and action;pathways in cancer;pancreatic cancer;choline metabolism in cancer"
choline salicylate,CHRNA7,5,hsa04020;hsa04080;hsa04725;hsa05033;hsa05204,calcium signaling pathway;neuroactive ligand-receptor interaction;cholinergic synapse;nicotine addiction;chemical carcinogenesis
methotrexate,DHFR,4,hsa00670;hsa00790;hsa01100;hsa01523,one carbon pool by folate;folate biosynthesis;metabolic pathways;antifolate resistance
methotrexate,TYMS,4,hsa00240;hsa00670;hsa01100;hsa01523,pyrimidine metabolism;one carbon pool by folate;metabolic pathways;antifolate resistance
methotrexate,ATIC,4,hsa00230;hsa00670;hsa01100;hsa01523,purine metabolism;one carbon pool by folate;metabolic pathways;antifolate resistance
clofibrate,PPARA,7,hsa03320;hsa04024;hsa04920;hsa04922;hsa04931;hsa04932;hsa05160,ppar signaling pathway;camp signaling pathway;adipocytokine signaling pathway;glucagon signaling pathway;insulin resistance;non-alcoholic fatty liver disease ;hepatitis c
hydroxyurea,RRM1,5,hsa00230;hsa00240;hsa00480;hsa00983;hsa01100,purine metabolism;pyrimidine metabolism;glutathione metabolism;drug metabolism - other enzymes;metabolic pathways
